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ABSTRACT OF THESIS 
 
 
 
 
 
EVALUATION OF NATURAL ANTIMICROBIAL PHENOLIC COMPOUNDS 
AGAINST FOODBORNE PATHOGENS 
 
 
Raw and processed foods are vulnerable to contamination during their production, 
distribution and sale. Thus, a wide variety of chemical preservatives are used in the food 
industry to prevent the growth of food spoilage and pathogenic bacteria. However, health 
and economic concerns have led to an intensive search for natural alternatives, such as 
plant extracts, that can safely be used as substitutes for synthetic antimicrobials and 
preservatives to partially or completely inhibit the growth of bacteria.  
This study evaluated the antimicrobial effects of natural phenolic compounds extracted 
from vegetables, fruits, herbs and spices. The main objective was to determine the lowest 
concentration of phenolics to inhibit the visible growth of the pathogenic bacteria which 
is defined as the minimum inhibitory concentration (MIC).   
Some of the most common Gram-positive and Gram-negative foodborne pathogens were 
treated with several natural phenolic compounds. Concentrations of 5, 10, 15, and 20 
ppm (pH 5-6) of each compound were evaluated by broth micro-dilution method and the 
MICs were determined by using official density (OD) assay.  
The results demonstrated that the phenolic compounds have varying antimicrobial 
activities against foodborne pathogens. Natural sources of phenolic compounds contain 
major antibacterial components and have great potential to be used as natural 
antimicrobials and food preservatives. 
KEYWORDS:  Foodborne Pathogen, Phenolic Compounds, Minimum Inhibitory     
Concentration (MIC), Antimicrobial Activity, Bacteria 
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CHAPTER 1 
INTRODUCTION 
A pathogen is a Greek word meaning “suffering, passion” and “I give birth to” which is 
an infectious agent, or more commonly referred as germ. It is a biological agent such as a 
virus, bacteria, prion, or fungus that causes disease to its host. Thus, pathogenic bacteria 
are responsible for causing bacterial infection. Although the vast majority of bacteria are 
harmless or even beneficial, quite a few types of them are pathogenic which can 
contribute to globally important diseases, such as pneumonia, and foodborne illnesses. 
Salmonella, Listeria, E.coli O157:H7 and Clostridium are a few species of them. 
Pathogenic bacteria also cause infections such as tetanus, typhoid fever, diphtheria, 
syphilis and leprosy (Microvet 2011). 
Although many medical advances have been made recently to safeguard against infection 
by pathogens through the use of vaccination, antibiotics, and fungicide, pathogens 
continue to threaten human life.  In entomology, pathogens are defined as one of the 
"Three P's" (predators, pathogens, and parasitoids) that serve as natural or introduced 
biological controls to suppress arthropod pest populations (Meta pathogen 2011). 
Food is the ideal vehicle for the dispersion of harmful agents which can cause life 
threatening foodborne illnesses. There are more than 80,000 chemicals and hundreds of 
naturally occurring biological pathogens, toxins, heavy metals, parasites that can cause 
serious illnesses. Food and food products are easily accessible at multiple points in any 
manufacturing process while they are easily distributed over great distances resulting in a 
great deal of concern for widespread impact of foodborne diseases. 
Foodborne disease is an increasingly serious public health problem all over the world. 
The main cause is determined to be microorganisms. The control of pathogens may 
significantly reduce the foodborne disease outbreaks (Ravi Kiran and others 2008). In 
recent years, polyphenols, the secondary plant metabolites, have received a great deal of 
attention due to their diverse biological functions. A considerable weight of evidence has 
been gathered suggesting that consumption of fruit and vegetables is beneficial for human 
health and may help in the prevention of chronic diseases (Liu 2003), because they 
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contain phenolic compounds (WHO/FAO 2002). Likewise, some natural substances have 
effective antimicrobial properties where they have been used as seasonings for centuries 
(Shelef 1984; Shan and others 2007a). Spices and aromatic vegetable materials have long 
been used in food not only for their flavor and fragrance qualities and appetizing effects 
but also for their preservative and medicinal properties. Since the ancient times, they 
have been used for preventing food spoilage and deterioration and also for extending the 
shelf life of foods (Shan and others 2007b). Laboratory attempts to characterize their 
prevention properties are dated back to the early 1900s. It has been extensively reported 
that the essential oils of spices have shown antimicrobial functions against foodborne 
pathogens (Smith and others 1998; Reichling and others 2009). Thus the secondary plant 
metabolites have received great attention in recent decades due to their presumed role in 
the cancer prevention (Kaefer and Milner 2008), as atherosclerosis preventing agents for 
cardiovascular diseases, and in the slowdown of the aging process (Nazzaro and others 
2009). In addition, they show other beneficial biological properties, such as antimicrobial 
and antioxidant activities (Kanner and others 1994; Fattouch and others 2007; Geoghegan 
and others 2010; Korukluoglu and others 2010; Perumalla and Hettiarachchy 2011).  
Because of the broad biochemical, nutritional and biological variations existing among 
the different cultivars/genotypes inside each species of fruit or vegetable, the 
identification of the best genotypes is important for breeders and consumers to have 
better quality products (Moreno and others 2006;  Nazzaro and others 2009; Emiroglu 
and others 2010; Korukluoglu and others 2010). 
Today, the use of plant drugs is accepted all over the world. About 57% of the top-selling 
prescription in the USA contains natural products or derivatives, and one out of three 
Americans consumes herbal drugs (Phillipson 2001; Newman and Cragg 2007). In 
developing countries, the use of medicinal plants has significantly increased due to the 
low income of the population. About 80% of the people are dependent, wholly or 
partially, on plant-based drugs (Kuete and others 2010). These findings explain why 
many research centers and universities have emphasized their search in the medicinal 
plant field. Herbs and spices are generally considered to be safe and proved to be 
effective against certain ailments. They are also extensively used, particularly, in many 
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Asian, African and other countries. In recent years, use of spices/herbs has been gradually 
increasing in developed countries (Indu and others 2006) since a number of studies linked 
the high consumption of vegetable and fruits to the prevention of chronic diseases (Lee 
and others 2003; Alviano and Alviano 2009). 
Interest in the antimicrobial properties of active compounds is strengthened by the 
findings that they affect the behavior of pathogenic bacteria or fungi of agro-food or 
medical field. Indeed, their use as natural additives in food industry is increased in recent 
years (Nazzaro and others 2009). The antimicrobial activity of phenolics and flavonoids 
are also well documented (Erdemoglu and others 2007; Milovanović and others 2007; 
Xia and others 2011a). The mechanisms responsible for phenolic toxicity to 
microorganisms include: adsorption and disruption of microbial membranes, interaction 
with enzymes, and metal ion deprivation (Fattouch and others 2007; Xia and others 
2011a). 
Due to their antibacterial, antifungal and antiviral activity, phenolic compounds and 
antioxidant biomolecules were the subject of anti-infective research for many years 
(Hulin and others 1998; Suppakul and others 2003; Lai and Roy 2004; Cushnie and Lamb 
2005; Fattouch and others 2007; Szabo and others 2010). These activities suggested that 
phenolic compounds can be used as chemotherapeutic agents, food preserving agents and 
disinfectants (Dorman and Deans 2000). They can affect the growth and metabolism of 
bacteria, activating or inhibiting the microbial growth according to their constitution and 
concentration (Alberto and others 2006; Nazzaro and others 2009). 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Food Safety 
The food system, just like the health care system, is vulnerable to natural and artificial 
adulteration and contamination. Food is the ideal vehicle for the dispersion of harmful 
agents because of the ability to mask the harmful agents by strong flavors, strong odors, 
various textures or intense colors. There are more than 80,000 chemicals that can cause 
illnesses, given the right concentration. In addition, there are hundreds of naturally 
occurring biological pathogens, toxins, heavy metals, parasites, radio-isotopes, 
genetically engineered organisms and other potential illness-causing agents. Food and 
food products are easily accessible at multiple points in any manufacturing process. 
Because food is so easily distributed over great distances, there is increased potential for 
widespread impact (Sobel and Watson 2009). 
Foodborne diseases, whether intentional or otherwise, can also paralyze public health 
services. Many countries do not have the capacity to respond to such massive 
emergencies. The public health services facilities for coping with these types of 
emergencies and for providing continuing care may be strained to the limit.  
World Health Organization (WHO) identifies foodborne disease outbreaks and incidents, 
including those arising from natural, accidental and deliberate contamination of food, as 
major global public health threats in the 21st Century.  These threats require urgent action, 
and WHO recognizes that the building of global public health security rests on solid and 
transparent partnerships. Full implementation of the International Health Regulations 
(2005), cross collaboration within governments, global cooperation in surveillance and 
outbreak preparedness, alert and response, open sharing of knowledge, technology and 
materials and capacity building in health security is necessary for Member States. 
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The five key principles of food safety, according to WHO are: 
1. Prevent contaminating food with pathogens spreading from people, pets, and 
pests. 
2. Separate raw and cooked foods to prevent contaminating the cooked foods. 
3. Cook foods for the appropriate length of time and at the appropriate temperature 
to kill pathogens. 
4. Store food at the proper temperature. 
5. Use safe water and raw materials. 
Making food safe in the first place is a major effort, involving the farm and fishery, the 
production plant or factory, and many other points from the farm to the table. Many 
different groups in public health, industry, regulatory agencies, and academia have roles 
to play in making the food supply less contaminated. Consumers can promote general 
food safety by purchasing foods that have been processed for safety. The new 
technologies are likely to be as important as a step forward as the pasteurization process. 
Milk pasteurization was a major advance in food safety that was developed 100 years 
ago. Buying pasteurized milk rather than raw unpasteurized milk still prevents an 
enormous number of foodborne diseases every day. Moreover, consuming pasteurized 
fruit juices and ciders prevents E. coli O157:H7 infections and many other diseases. 
We live in a microbial world, and there are many opportunities for food to become 
contaminated as it is produced and prepared (CDC 2011).  
 Many foodborne microbes are present in healthy animals (usually in their 
intestines) raised for food. Meat and poultry carcasses can become contaminated 
during slaughter by contact with small amounts of intestinal contents.  
 Similarly, fresh fruits and vegetables can be contaminated if they are washed or 
irrigated with water that is contaminated with animal manure or human sewage.  
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 Some types of Salmonella can infect a hen's ovary so that the internal contents of 
a normal looking egg can be contaminated with Salmonella even before the shell 
in formed.  
 Oysters and other filter feeding shellfish can concentrate Vibrio species that are 
naturally present in sea water, or other microorganisms that are present in human 
sewage dumped into the sea. 
Later in food processing, other foodborne microorganisms can be introduced from 
infected humans who handle the food or by cross-contamination from some other raw 
agricultural products. 
 For example, Shigella species, hepatitis A virus and Norwalk virus can be 
introduced by the unwashed hands of food handlers who are themselves infected.  
 In the kitchen, microorganisms can be transferred from one food to another food 
by using the same knife, cutting board or other utensil to prepare both, without 
washing the surface or utensil in between.  
 A food that is fully cooked can become re-contaminated if it touches other raw 
foods or drippings from raw foods that contain pathogens. 
The way that food is handled after it is contaminated can also make a difference in 
whether or not an outbreak occurs.  
 Many bacteria need to multiply to a larger number before enough are present in 
food to cause disease. Given warm moist conditions and sufficient supply of 
nutrients, one bacterium that reproduces by dividing itself every half hour can 
produce 17 million progeny in 12 hours.  
 As a result, lightly contaminated food left out overnight can be highly infectious 
by the next day. If the food were refrigerated promptly, the bacteria would not 
multiply at all.  
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 In general, refrigeration or freezing prevents virtually all bacteria from growing 
but generally preserves them in a state of suspended animation. This general rule 
has a few surprising exceptions.  
o Two foodborne bacteria, Listeria monocytogenes and Yersinia 
enterocolitica can actually grow at refrigerator temperatures.  
 High salt, high sugar or high acid levels keep bacteria from growing, which is 
why salted meats, jam, and pickled vegetables are traditional preserved foods. 
Microorganisms may be killed by heat. 
 If food is heated to an internal temperature above 160oF, or 78oC, for even a few 
seconds is sufficient to kill parasites, viruses or bacteria, except for the 
Clostridium, which produce heat-resistant spores.  
o Clostridium spores are killed only at temperatures above boiling. This is 
why canned foods must be cooked to a high temperature under pressure as 
part of the canning process. 
 The toxins produced by bacteria vary in their sensitivity to heat.  
o The staphylococcal toxin which causes vomiting is not inactivated even if 
it is boiled. 
o Fortunately, the potent toxin that causes botulism is completely inactivated 
by boiling. 
In order to reduce the burden of foodborne diseases, the food safety systems in many 
countries are intended to ensure the safety of the food supply. These often include safety 
management programs for food production, processing and distribution, which can be 
modified to incorporate basic consideration of food sabotage (Alvarez and others 2010). 
The food industry has the primary responsibility for assuring the safety of the food they 
produce; government agencies, working with the private sector, have regulatory and 
advisory responsibilities in promoting safe food practices by industry, such as good 
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agricultural and manufacturing practices (Sobel and Watson 2009; Ceuppens and others 
2011; Gravani 2011; Nachay 2011; Toure and others 2011; Szeitz-Szabo and Farkas 
2011). 
In May 2010 the World Health Assembly (WHA) approved a new resolution on food 
safety: Advancing food safety initiatives (WHA 63.3). This resolution will be used to 
update the current WHO Global Strategy for Food Safety. 
Cost provides another measure for assessing the need for action on foodborne illnesses. 
The U. S. Department of Agriculture’s (USDA) Economic Research Service estimated 
the economic costs of hospitalizations and lost productivity from the five most common 
pathogens as $ 6.9 billion in 2000. The greatest percent of this cost is from premature 
death which occurs primarily in people over age 65 for Salmonella and children under 
age five for E. coli O157:H7. The elderly, people with compromised immune systems, 
pregnant women, children and infants are most at risk of serious illness from foodborne 
disease. Many pathogens, including Salmonella, Campylobacter and pathogenic E. coli 
can lead to chronic illness and reduced life expectancy.  
The heart of a modern food safety system lies in preventing “not merely responding” to 
food safety problems. Mandatory process controls, coupled with government enforced 
performance standards, should be the central features of a new system. The systems can 
be used from farm-to-table and with both domestic and imported foods. 
Most foodborne illnesses are the result of contamination that occurs during production, 
processing, shipping or handling. These lapses result in illness, recalls, and loss of public 
confidence in the safety of our food supply. While in-plant and border inspection from 
the core of the government’s food safety program, inspection is often little more than a 
spot check on performance. The reality is that the industry holds the key to addressing 
and preventing food contamination. 
The safety and security of the food supply requires an integrated, system-wide approach 
to preventing foodborne illness, with oversight by federal food safety agencies. 
Preventing food contamination can be done using programs of quality assurance and 
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preventive process control, such as Hazard Analysis and Critical Control Points 
(HACCP) that are developed by individual companies. These programs are already 
widely used, and they can be incorporated into food production systems at all levels. 
HACCP systems are already mandated in some segments of the food supply, including 
seafood, juice, and all types of meat and poultry products, both raw and processed. A 
modern food safety system mandated by Congress requires FDA to implement HACCP 
or HACCP-like systems for all food processors and tie agency inspections to and audit of 
these systems. These industry derived programs should be coupled with performance 
standards, such as limits on the incidence or levels of contamination, or reductions in 
pathogen levels, that are established by the government. Monitoring and enforcement of 
the standards are key elements of inspection in a successful food safety program. This 
includes laboratory testing to ensure that process controls are working effectively. 
Research is a vital tool in the effort to reduce the incidence of foodborne illness and is 
integral to the programs of all public health agencies. Research is needed to evaluate the 
effectiveness of control and prevention strategies and to conduct risk assessments. It is 
also needed to improve sanitation and food safety practices during processing. Public 
education is another essential component of improved food safety. Rates of illness could 
be reduced if food preparers and handlers were informed of risks and related safe 
handling practices. Educational programs that promote better understanding and practice 
of proper food safety techniques, such as thoroughly washing hands and cooking foods to 
proper temperatures, could significantly reduce foodborne illness. Programs are also 
needed help health professionals improve their diagnosis and treatment of food related 
illness and to advise individuals at special risk (DeWaal and others 2010). 
 
2.2 Foodborne Diseases and Statistics 
Foodborne illness, sometimes called “foodborne disease”, “foodborne infection”, or 
“food poisoning”, is a common, costly-yet preventable-public health problem. Center for 
Disease Control (CDC) and WHO estimates that each year roughly 1 in 6 Americans (or 
76 million people) get sick by consuming contaminated foods or beverages, 325,000 are 
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hospitalized, and 5,000 die of foodborne diseases. A 2003 World Health Organization 
(WHO) report concluded that about 40% of reported food poisoning outbreaks in the 
WHO European Region occur in private homes. Due to a wide variety of disease-causing 
microbes, or pathogens, poisonous chemicals, or other harmful substances having the 
potential to contaminate foods, there are many different foodborne infections. The 2011 
CDC Estimates Report provides the most accurate picture yet of which foodborne 
bacteria, viruses, microbes (pathogens) are causing the most illnesses in the United 
States, as well as estimating the number of foodborne illnesses without a known cause.  
More than 250 different foodborne diseases have been described and most of these 
diseases are infections, caused by a variety of bacteria, viruses, and parasites that can be 
foodborne. Other diseases are poisonings, caused by harmful toxins or chemicals that 
have contaminated the food (i.e. poisonous mushrooms). These different diseases have 
many different symptoms, so there is no one "syndrome" confirming the foodborne 
illness. However, the microbe or toxin enters the body through the gastrointestinal tract, 
often causing the first symptoms there. The common symptoms in many foodborne 
diseases may include nausea, vomiting, abdominal cramps and diarrhea (Scallan 2010). 
Many microorganisms can spread in more than one way, so we cannot always know that 
a disease is foodborne. The distinction matters, because public health authorities need to 
know how a particular disease is spreading to take the appropriate steps to stop it. For 
example, Escherichia coli O157:H7 infections can spread through contaminated food, 
contaminated drinking water, contaminated swimming water, and from toddler to toddler 
at a day care center.   
According to CDC's 2011 Estimates for Foodborne Illness Report eight known pathogens 
account for the vast majority of illnesses, hospitalizations, and deaths. Tables 2.1- 2.3 list 
the top five pathogens causing illness, hospitalization, and death.  
Foodborne diseases are largely preventable, though there is no simple one-step 
prevention measure like a vaccine. Instead, measures are needed to prevent or limit 
contamination all the way from the farm to the table.  
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 A variety of good agricultural and manufacturing practices can reduce the spread 
of microbes among animals and prevent the contamination of foods.  
 Careful review of the whole food production process can identify the principal 
hazards, and the control points where contamination can be prevented, limited, or 
eliminated.  
 A formal method for evaluating the control of risk in foods exists is called the 
Hazard Analysis Critical Control Point (HACCP) system, which was first 
developed by NASA to make sure that the food eaten by astronauts was safe. 
HACCP safety principles are now being applied to an increasing spectrum of 
foods, including meat, poultry, and seafood. 
For some particularly risky foods, even the most careful hygiene and sanitation are 
insufficient to prevent contamination, and a definitive microbe-killing step must be 
included in the process. 
In the end, it is up to the consumer to demand a safe food supply; up to industry to 
produce it; up to researchers to develop better ways of doing so; and up to government to 
see that it happens, to make sure it works and to identify problems still in need of 
solutions (CDC 2011). 
 
2.3 Generally Recognized as Safe (GRAS) 
"GRAS" is an acronym for the phrase Generally Recognized As Safe, which is an 
American Food and Drug Administration (FDA) designation that a chemical or substance 
added to food is considered safe by experts, and so is exempted from the usual Federal 
Food, Drug, and Cosmetic Act (FFDCA) food additive tolerance requirements. In 1958, 
the FDA established the “Food Additives Amendment of 1958”, with a list of 700 food 
substances that were exempt from the new requirement that manufacturers test food 
additives before putting them on the market. Then, the enforcement provisions of the 
"Food Additives Amendment of 1958" referred to as GRAS. 
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Under sections 201(s) and 409 of the FFDCA, any substance that is intentionally added to 
food is a food additive, that is subject to premarket review and approval by FDA, unless 
the substance is generally recognized among qualified experts, as having been adequately 
shown to be safe under the conditions of its intended use, or unless the use of the 
substance is otherwise excluded from the definition of a food additive (FDA 2011).  
According to the FFDCA and FDA's implementing regulations (21 CFR 170.3 and 21 
CFR 170.30), the use of a food substance may be GRAS either through scientific 
procedures or, for a substance used in food before 1958, through experience based on 
common use in food, which requires a substantial history of consumption for food use by 
a significant number of consumers. 
General recognition of safety through scientific procedures requires the same quantity 
and quality of scientific evidence as is required to obtain approval of the substance as a 
food additive and ordinarily is based upon published studies, which may be corroborated 
by unpublished studies and other data and information (FDA 2011b). The GRAS process, 
when carried out with due diligence, is a robust, comprehensive, and transparent safety 
evaluation process. At its essence, GRAS is a scientific peer-review process that is based 
on widespread knowledge among a community of qualified experts and relies on publicly 
available scientific evidence to support reasonable certainty in the minds of these 
competent scientists that the substance is not harmful under its intended conditions of use 
(Kruger and others 2011). 
Regardless of whether the use of a substance as a food additive or is GRAS, there must 
be evidence that the substance is safe under the conditions of its intended use. FDA has 
defined “safe” (21 CFR 170.3(i)) as a reasonable certainty in the minds of competent 
scientists that the substance is not harmful under its intended conditions of use. The 
specific data and information that demonstrate safety depend on the characteristics of the 
substance, the estimated dietary intake, and the population that will consume the 
substance. 
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2.4.  Phenolic Compounds 
In the last two decades, there has been an increase in the incidence and detection of food-
borne diseases together with increasing consumer demand for foods containing reduced 
levels of chemically-synthesized food additives. Consequently, antimicrobial compounds 
derived from various plants, animals and microorganisms have constituted a locus of 
renewed interest as potentially natural substitutes for chemical food preservatives (Roller 
and Lusengo 1997). 
Phenolic compounds are one of the most diverse groups of secondary metabolites found 
in edible plants. They are found in a wide variety of fruits, vegetables, nuts, seeds, stems 
and flowers as well as tea, wine, propolis and honey (Table 2.5), and represent a common 
constituent of the human diet. In nature they are involved in plant growth and 
reproduction, provide resistance from pathogens and predators and protect crops from 
disease and pre-harvest seed germination (Ross and Kasum 2002). There are different 
classes of polyphenols known as tannins, lignins and flavonoids. Each class of 
polyphenols possesses chemical characteristics that set them apart from one another 
(Figure 2.1).  Flavonoids are the most widely occurring polyphenol and are present in 
almost every form of human consumed vegetation. Dietary flavonoids have attracted 
interest because they have a variety of beneficial biological properties, which may play 
an important role in the maintenance of human health.  Flavonoids are potent 
antioxidants, free radical scavengers and metal chelators; they inhibit lipid peroxidation 
and exhibit various physiological activities including anti-inflammatory, anti-allergic, 
anti-carcinogenic, anti-hypertensive, anti-arthritic and antimicrobial activities. 
 Consumption of phenol-rich beverages, fruit and vegetables has commonly been 
associated to a reducing of the risk of cardiovascular diseases in epidemiological studies. 
With over 9000 natural compounds identified in nature the flavonoid family is the largest 
group of polyphenolic compounds (Whiting 2001). Flavonoids have been found to be the 
most abundant polyphenols in our diets. The biosynthesis of flavonoids is stimulated by 
sunlight (ultraviolet radiation), so higher concentrations of flavonoids can typically be 
found in the outer most layers of fruits and vegetables (i.e. the skins). Flavonoids can be 
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divided into six subclasses according to the degree of oxidation of the oxygen 
heterocycle: flavones, flavonols, isoflavones, anthocyanins, flavanones and flavonols 
(catechins and anthocyanidins). Extraction of polyphenols can be performed using a 
solvent like water, hot water, methanol, methanol/formic acid, methanol/water/acetic or 
formic acid etc. Therefore, the total polyphenol amounts detected from the same plant 
and their corresponding antioxidant and antimicrobial activities may vary widely, 
depending on external conditions applied.  
SUB-CLASSES OF THE COMMON FLAVONOIDS 
Flavones: apigenin, luteloin, diosmetin 
Flavonols: quercetin, myricetin, rutin 
Flavanones: naringenin, hesperidin 
Catechins (flavanols): (-) epicatechin, gallocatechin, (+) catechin 
Anthocyanidins: pelargonidin, malvidin, cyanidin 
Isoflavones: genistein, daidzein 
Phenolic acids: chlorogenic aicd, tannic acid, ferulic acid 
(Puupponen-Pimia and others 2001) 
Although earlier studies were focused on the mutagenic and genotoxic activity of 
phenolics, later epidemiological studies have indicated that phenolic compounds may 
play an important role in the prevention of several common diseases, including foodborne 
diseases (Cueva and others 2010).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
Food contamination and spoilage by microorganisms are a serious problem because they 
have not yet been brought under adequate control despite the new preservation techniques 
available. Foodborne illnesses resulting from consumption of food contaminated with 
pathogenic bacteria has been of vital concern to public health.  Unfortunately there is a 
dramatic increase throughout the world in the number of reported cases of foodborne 
illness.  To reduce the incidence of food poisoning and spoilage by pathogenic 
microorganisms many synthetic chemicals were utilized. The exploration of natural 
antimicrobials for food preservation receives increased attention due to consumer 
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awareness of natural food products and a growing concern of microbial resistance 
towards conventional preservatives. The use of phenolic compounds as antimicrobial 
agents would provide additional benefits, including dual-function effects of both 
preservation and delivery health benefits.  Knowing the antimicrobial effect of the 
phenolic compounds from several kinds of edible plants on the principal pathogenic 
microorganisms from the different foods, it is possible to search new strategies to 
combine the synergic antimicrobial effects of phenolic compounds with their natural 
biological properties.  The results may possibly permit to formulate new products to be 
used as food preservatives or to be included in the human diet.  
 
2.4.1. Mechanism of Action 
It was reported that an antimicrobial action of phenolic compounds was related to 
inactivation of cellular enzymes, which depended on the rate of penetration of the 
substance into the cell or caused by membrane permeability changes (Moreno and others 
2006). Increased membrane permeability is a major factor in the mechanism of 
antimicrobial action, where compounds may disrupt membranes and cause a loss of 
cellular integrity and eventual cell death.  
Human gut microbiota plays key roles in multiple host functions, including protection 
against pathogenic organisms, immunomodulation, the production of essential nutrients 
and the degradation of xenobiotic compounds. Diet is a major factor determining the 
composition and evolution of the gut microbiota. In fact, the bacterial conversion of 
carbohydrates, proteins and non-nutritive compounds such as phenolic compounds leads 
to the formation of a large number of compounds that may have beneficial or adverse 
effects on human health (Blaut and Clavel 2007). 
In general, phenolic compounds are poorly absorbed in the small intestine; it is estimated 
that 90-95% of dietary phenolics accumulate in the colon (Clifford 2004). In the gut, 
phenolics may selectively suppress or stimulate the growth of some components of 
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intestinal microbiota; consequently, they may influence bacterial population dynamics 
(Tzounis and others 2008). 
However, interactions between phenolics and gastrointestinal bacteria are still poorly 
understood. Among the different classes of phenolic compounds, phenolic acids (i.e., 
benzoic, phenylacetic and phenylpropionic acids, and other aromatic acids are the 
predominant structures found in fecal water (Jenner and others 2005). Although some of 
these acids could originate directly from dietary or endogenous sources, most are thought 
to come from the microbial metabolism of other dietary phenolic compounds (mainly 
flavan-3-ols, flavonols, flavones and anthocyanins) (Aura 2008). The fecal phenolic acid 
profile seems to vary widely, depending on the phenolic compounds ingested.  
Recently, microbial-derived phenolic acids have been implicated in providing a variety of 
health benefits to the host, such as the inhibition of platelet aggregation (Rechner and 
Kroner 2005) and antiproliferative activity in prostatic and tumoral cells (Gao and others 
2006). In addition, the antimicrobial activity of specific phenolic acids towards beneficial 
gut bacteria and pathogens has been assessed while evaluating the antimicrobial 
properties of pure phenolics and plant extracts. The Escherichia coli species includes 
non-pathogenic, pathogenic and commensal bacterial strains that generally inhabit the 
normal human gut. E. coli O157:H7 is a foodborne pathogen that causes 
enterohemorrhagic infection and, occasionally, kidney failure. Thus, E. coli strains are 
widely used in antimicrobial screening studies, in conjunction with other beneficial and 
pathogenic bacteria. 
Multivariate statistical analyses have been applied to confirm similarities and differences 
among phenolic acids based on their antimicrobial potency. In general, variations in 
antimicrobial activities among bacteria may reflect differences in cell surface structures 
between Gram-negative and Gram-positive species. Lactobacillus spp. and S. aureus 
(Gram-positive) appeared more susceptible to the action of phenolic acids than Gram-
negative bacteria such as E. coli and P. aeruginosa. Mutations of the lpxC and tolC genes 
on E. coli seemed to amplify the phenolic acid antimicrobial mechanisms of action 
against Gram-negative species. 
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Also, the number and position of substitutions in the benzene ring of the phenolic acids 
and the saturated side-chain length influenced the antimicrobial potential of the phenolic 
acids against the different microorganisms, but in different ways. Phenolic acids seemed 
to show greater antimicrobial potency than their corresponding precursors such as the 
monomers (þ)-catechin, (-) epicatechin and dimers B1 and B2. Therefore, microbial 
transformations of dietary phenolics (flavonols, flavan-3-ols, flavones and anthocyanins) 
could lead to more potent microbial-inhibitory compounds (phenolic acids) that 
selectively influence intestinal bacteria species. These transformations could affect the 
diversity and metabolic activity of the intestinal microbiota, including the transformation 
of phenolics in the gut. Further studies taking into account the diversity and complexity 
of the human microbiota are required in order to confirm the potential microbiota 
modulating effects of phenolic acids (Cueva and others 2010). 
Active compounds such as thymol, eugenol, and carvacrol have been shown to cause 
disruption of the cellular membrane, inhibition of ATPase activity, and release of 
intracellular ATP and other constituents of several microorganisms such as E. coli, E. coli 
O157:H7, L. monocytogenes, Lactobacillus sakei, Pseudomonas aeruginosa, Salmonella 
enteritidis, and S. aureus (Lambert and others 2001; Gill and Holley 2006; Oussalah and 
others 2006; Raybaudi-Massilia and others 2006). However, Oussalah and others (2006) 
and Gill and Holley (2004, 2006) indicated that cinnamon oil and cinnamaldehyde 
produced a decrease in the intracellular ATP by ATPase activity without apparent 
changes on the cell membrane of E. coli, E. coli O157:H7, and L. monocytogenes. This 
fact could be attributed to interaction of cinnamaldehyde with the cell membrane, which 
may cause enough disruption to disperse the proton motive force by leakage of small ions 
but without leakage of larger cell molecules such as ATP (Raybaudi-Massilia and others 
2009). 
Organic acids are used in food preservation because of their effects on bacteria. The key 
basic principle on the mode of action of organic acids on bacteria is that non-dissociated 
(non-ionized) organic acids can penetrate the bacteria cell wall and disrupt the normal 
physiology of certain types of bacteria that we call pH-sensitive, meaning that they 
cannot tolerate a wide internal and external pH gradient (Figure 2.2). Among those 
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bacteria are Escherichia coli, Salmonella spp., Clostridium perfringens, Listeria 
monocytogenes, and Campylobacter species. 
Upon passive diffusion of organic acids into the bacteria, where the pH is near or above 
neutrality, the acids will dissociate and lower the bacteria internal pH, leading to 
situations that will impair or stop the growth of bacteria. On the other hand, the anionic 
part of the organic acids that cannot escape the bacteria in its dissociated form will 
accumulate within the bacteria and disrupt many metabolic functions, leading to osmotic 
pressure increase, incompatible with the survival of the bacteria. 
Essential oils, which are concentrated hydrophobic liquid containing volatile aroma 
compounds from plants, provide a wide research area as well. According to Burt (2004) it 
is most likely that the antibacterial activity of the essential oils is not attributable to one 
specific mechanism but to action over several specific targets in the cell. Nychas and 
Tassou (1999) have reported the location and mechanisms of action in the bacterial cell 
of bioactive plant compounds, for instance: degradation of the cell wall, damage to 
cytoplasmic membrane and membrane proteins (Lambert and others 2001), leakage 
contents out of the cell, coagulation of cytoplasm (Burt 2004), and depletion of the proton 
motive force (Figure 2.3). Raybaudi-Massilia and others (2009) indicated that the mode 
of action of essential oils is concentration dependent, indicating that low concentrations 
inhibit enzymes associated with energy production, while higher amounts may precipitate 
proteins.  
Nisin, a small, heat-stable antimicrobial peptide of 34 amino acids produced by 
Lactococcus lactis subsp. lactis (Davidson and Zivanovic 2003), has shown a narrow 
antimicrobial spectrum, inhibiting only Gram-positive bacteria, including 
Alicyclobacillus, Bacillus cereus, Brochothrix thermosphacta, Clostridium botulinum, 
Clostridium sporogenes, Desulfotomaculum, Enterococcus, Lactobacillus, Leuconostoc, 
L. monocytogenes, Micrococcus, Pediococcus, Sporolactobacillus, and Staphylococcus. 
Against bacterial spores, nisin is sporostatic rather than sporicidal. On the other hand, 
nisin does not generally inhibit Gram-negative bacteria, yeasts, or molds.  
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In vegetative cells the primary site of action for nisin is the cytoplasmic membrane where 
it forms pores, thus destroying membrane integrity (Figure 2.4), and acts as a voltage-
dependent polarizer (Abee and others 1994; Ross and others 2003). Pore formation 
results in depletion of proton motive force (Raybaudi-Massilia and others 2009) and loss 
of cellular ions, amino acids, and ATP (Crandall and Montville 1998; Davidson and 
Zivanovic 2003). 
 
2.4.2.   Antimicrobial Resistance  
The discovery of effective agents to prevent and treat infections caused by bacteria and 
other pathogenic microorganisms has been one of the most important developments of 
modern medicine (Thomson and others 1994b). Undertaking laboratory testing of 
organisms causing infections can play a role in deciding the most effective treatment 
options. 
However, microorganisms have a short generation time -from minutes to hours- can 
therefore respond rapidly to changes in their environment. Thus, as antimicrobial agents 
are introduced into the environment, microorganisms respond to the selective pressure of 
these agents by becoming resistant, that is able to survive and reproduce in the presence 
of the agent (Aminov and Mackie 2007). In a few instances some micro-organism are 
naturally resistant to particular antimicrobial agents, but a more common problem is 
when micro-organisms that are normally susceptible to the action of particular 
antimicrobial agents become resistant (HPA 2011).  
Multiple mechanism of acquired resistance results from changes in the cellular 
physiology and structure of a microorganism due to alterations in its usual genetic 
makeup. There are three main mechanisms whereby bacteria initially susceptible to an 
antimicrobial agent may acquire the ability to resist the effects of an agent (Thomson and 
others 1994a). These include:  
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1. Prevention of intracellular antimicrobial agent/drug accumulation by: 
 alterations in the bacterial outer membrane, such that the antimicrobial 
agent/drug no longer binds to the exterior of the microorganism 
 active transport of the antimicrobial agent/drug across the cytoplasmic 
membrane in the cell ceases, or 
 active efflux (pumping) of the antimicrobial agent/drug out of the cell before 
it can damage the micro-organism 
2. Alteration in the antimicrobial agent/drug target (the part of the microorganism where 
damage is done) which leads to ineffective levels of antimicrobial agent/drug binding to 
or near the target site. 
3. Production by the microorganism of an antimicrobial agent/drug inactivating enzyme 
that destroys or greatly diminishes the antimicrobial agent/drug’s ability to kill the 
microorganism. 
Many of these mechanisms result from genetic mutations, the acquisition of resistance 
genes from other microorganisms via gene transfer, and combinations of these two types 
of events. In some cases, the genes causing resistance can be transferred between 
different strains of microorganism, and when this happens the recipient organisms will 
also become resistant. Irrespective of how they arise, resistant microorganisms may 
spread and it seems likely that the extensive use of antimicrobial agents helps this process 
along by eliminating competing susceptible microorganisms. 
The consequences of increasing resistance are enormous. Resistance leads to increased 
morbidity and mortality, the need to use more toxic and expensive therapies, and the need 
to expend ever greater resources on monitoring the development of resistance and 
surveillance. The origins of the current crisis in antimicrobial resistance are complex and 
may differ somewhat for hospital and community-acquired pathogens and for developed 
and underdeveloped countries. Due to the inappropriate use of antimicrobials, such as 
ineffective doses, for an inadequate or in appropriate length of time, antimicrobial agents 
can not only be ineffective, but exert strong selective pressures upon bacterial 
populations, favoring those organisms that are capable of resisting them (Sanders and 
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Sanders 1995). In addition to human uses of antimicrobial agents, there are a number of 
non-human applications that increases the pool of resistant organisms that may impact the 
clinical effectiveness of many antimicrobial agents used to treat infectious diseases of 
man. These applications include production of food animals (livestock, poultry), 
aquaculture, plant and crop protection, and food production. 
It is reported that pathogenic isolates have a relatively large potential for developing 
antibiotic resistance advantage (Fluit and others 2000). The increase in antibiotic resistant 
bacteria is largely due to the widespread use of antibiotics in medicine, in animal care and 
in agriculture (SENTRY 1998). The problem is compounded by the lack of new 
antibiotics to attack bacteria in different ways to circumvent the resistant genes. 
Therefore, finding antimicrobial agents which are effective or might enhance the 
antibiotic efficacy against resistant bacteria would be an advantage (Darwish and others 
2010). 
 
2.4.3.   Food Applications 
Concerns and potential risks regarding the use of synthetic chemical antimicrobials and 
antioxidants have renewed the interests of consumers using natural and safe alternatives. 
To address the need for natural and safe alternatives, several plant extracts have been 
used in the food industry for years (Biswas and others 2002). Previous studies have 
reported that natural plant extracts have the potential to improve the overall quality and 
extend the shelf life of food products (Biswas et al. 2002; Raman and others 2009; 
Bussmann and others 2010; Mubarak Ali and others 2011). Furthermore, they can also be 
used in various food model systems such as meat (turkey, beef, and chicken), seafood 
(Miladi and others 2010), vegetable produce (spinach), probiotics, and packaging films 
(Cagri and others 2001, 2003) along with other multiple hurdle technologies 
(bacteriocins, organic acids, temperature, and packaging) to improve the overall 
microbial quality and safety of the food products (Serra and others 2008; Nazzaro and 
others 2009; Patra and Thatoi 2011; Perumalla and Hettiarachchy 2011).  
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Different natural antimicrobials of animal, plant, and microbial origin, directly or 
indirectly added to fresh-cut fruits and fruit juices, reported effectively to reduce or 
inhibit pathogenic and spoilage microorganisms, thus representing a good alternative to 
the use of traditional antimicrobials (Raybaudi-Massilia and others 2009; Mulaudzi and 
others 2011). On the other hand, the addition of antimicrobials to these products without 
adversely affecting the sensory characteristics is still a challenge for researchers, since 
the concentrations that are necessary to ensure safety (up to 5 log CFU/g reductions in the 
most resistant pathogenic microorganism, based on USFDA (2002) regulation) of natural 
fruit and vegetable extracts are several times higher than those accepted by consumers 
from sensory point of view (Peixoto and others 2011). Therefore, new studies combining 
the use of antimicrobials with other methodologies of food preservation are necessary to 
reduce the impact of these compounds on sensory properties (Raybaudi-Massilia and 
others 2009). 
Moreover, different studies have demonstrated the effectiveness of essential oils and their 
active compounds to control or inhibit the growth of pathogenic and spoilage 
microorganisms in both fresh-cut fruit and fruit juices. That effectiveness depended on 
the pH of the fruit product, kind and concentration of used essential oils or active 
compound, and microorganism type. In this way, Raybaudi-Massilia and others (2009) 
incorporated active compounds of herbs and spices into an alginate-based edible coating 
and applied on fresh-cut apples where they found a high effectiveness for reducing 
populations of inoculated E. coli O157:H7 during storage time.  
Several agents were previously used to suppress contamination by L. monocytogenes, 
such as the addition of bio-preservatives and essential oils. Active compounds from clove 
oil had antimicrobial properties and were able to restrict the proliferation of L. 
monocytogenes in food products. For this reason, clove oil has good potential as an 
antilisterial substance in food preservation as it may be more acceptable to consumers 
(Miladi and others 2010). Antimicrobial and antioxidant activities of edible coatings 
enriched with rosemary and olive oleoresins studied in vitro and in vivo, which offered a 
great advantage in the prevention of bacterial population and browning reactions which 
typically result in quality loss in fruits and vegetables (Ponce and others 2008). 
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According to Ceylan and others (2004) addition of cinnamon into apple juice gradually 
decreased the number of E. coli O157:H7 at 8°C and 25°C. Cinnamon in combination 
with sodium benzoate or potassium sorbate reduced the number of E. coli O157:H7 more 
than 5.0 log CFU/mL during storage at 8°C for 14 days and 25°C for 3 days.  In fact, 
cinnamon in food systems with other extrinsic and intrinsic factors (for example, 
acidulation with organic acids) might provide a hurdle effect to control E. coli. 
Antibacterial activity of soy protein edible films (SPEF) incorporated with oregano or 
thyme essential oils were evaluated against Escherichia coli, E. coli O157:H7, 
Staphylococcus aureus, Pseudomonas aeruginosa and Lactobacillus plantarum 
(Emiroglu and others 2010). Due to the complexity of ground beef matrix using essential 
oils incorporated films resulted in limited reduction of antimicrobial activity of 
Pseudomonas spp. and coliform bacteria in ground beef patties during refrigerated 
storage.  
 
2.5 Antimicrobial Susceptibility Testing 
One of the most important tasks of the clinical microbiology laboratory is the 
performance of antimicrobial susceptibility tests. The goal of a susceptibility test is to 
predict through an in vitro assessment of successfully finding sensitivity or resistance to a 
particular antimicrobial agent.  
Antimicrobial agents are chemicals that kill or inhibit the growth of micro-organisms and 
are used to treat microbial infections. Some are produced naturally by microbes but many 
are synthetic. Antimicrobials include antibiotics, antivirals, antifungals and other natural 
plant bioactive compounds such as phenolics. Susceptibility testing is most important 
with bacterial species that are not predictably susceptible to drugs and/or compounds of 
choice for infections such as, staphylococci, enterococci, pneumococcus, and foodborne 
diseases including, salmonellosis, gastroenteritis, and hemolytic-uremic syndrome. The 
natural history of the infection and the immune status of the patient must be taken into 
consideration. The pharmacological properties of the antibiotics must also be considered; 
ease of absorption, protein-binding, metabolism, ability to reach the site of infection, and 
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excretion. The most important function of a susceptibility test is the detection of 
clinically relevant antimicrobial resistance in etiologic agents causing an infection, 
including foodborne infections (Murray and others 2005). 
 
2.5.1 Antibacterial Susceptibility Tests 
Antibacterial susceptibility testing may be performed by either dilution or diffusion 
methods. The choice of methodology is often based on many factors, including relative 
ease of performance, flexibility, use of automated or semi-automated devices for both 
identification and susceptibility testing (Murray and others 2005). 
 
2.5.1.1 Dilution Methods 
Dilution susceptibility testing methods are used to determine the minimal concentration, 
usually expressed in micrograms per milliliter of antimicrobial agents required to inhibit 
or kill a microorganism. Procedures for determining the antimicrobial inhibitory activity 
are carried out by either agar or broth based methods. Antimicrobial agents are usually 
tested as log2 (twofold) serial dilutions, and the lowest concentration that inhibits visible 
growth of an organism is recorded as the MIC. The concentration range used may vary 
with the compound, organism identification, and site of infection. Generally ranges 
should include concentrations that allow determination of the interpretive categories such 
as, susceptible, intermediate, and resistant (Murray and others 2005). Serial dilutions are 
made of the products in bacterial growth media. The test organisms are then incorporated 
into the dilutions of the products, incubated, and scored for growth.  
Dilution methods offer flexibility in the sense that the standard medium used to test 
routinely encountered microorganisms (e.g., staphylococci, members of the family 
Enterobacteriaceae, Pseudomonas aeruginosa) may be readily supplemented or even 
replaced with another medium to allow accurate testing of various fastidious bacteria not 
reliably tested by disk diffusion.  Dilution methods are also adaptable to automated 
25 
 
systems and they provide quantitative results (MICs in micrograms per milliliter) or 
category results (susceptible, intermediate, or resistant) without any need for conversion 
or regression lines. Mechanization and automation have made broth dilution 
susceptibility testing much less time consuming, and fluid systems are used almost 
without exception in advanced, automated tests.  
The general approaches for broth methods include macro-broth dilution, in which the 
broth volume for each antimicrobial concentration is ≥ 1.0 ml contained in test tubes and 
micro-broth dilution, in which antimicrobial dilutions are in 0.05 to 0.1 ml volumes 
contained in wells of micro-titer trays. The macro-broth dilution broth method is a well-
standardized and reliable reference method that is useful for research purposes, but 
because of the laborious nature of the procedure and the availability of more convenient 
dilution systems (i.e., micro dilution), this procedure is generally not useful for routine 
susceptibility testing. 
In the present study, the micro-broth dilution testing method is performed, which has 
always been considered a primary laboratory approach to the study of the in vitro 
antimicrobial susceptibilities of pathogenic organisms (Shan and others 2007a). The 
convenience of the micro-broth dilution susceptibility testing is afforded by the 
availability of the testing in micro dilution trays. The inoculation and reading procedures 
allow relatively convenient simultaneous testing of several antimicrobial agents against 
individual organisms, also the results of testing may be determined by visual examination 
or with semi-automated or automated instrumentation (i.e., spectrophotometry) (Murray 
and others 2005). 
 
2.5.1.2 Disk Diffusion Testing 
Disc diffusion tests were introduced mainly because they were less cumbersome 
technically when large numbers of organisms were tested against many antimicrobials 
including antibiotics (Shan and others 2007b). 
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The disk diffusion method of susceptibility testing allows categorization of bacterial 
isolates as susceptible, resistant, or intermediate to a variety of antimicrobial agents. It is 
technically simple to perform and very reproducible. Moreover, it does not require any 
special equipment and provides category results that are easily interpreted by clinicians. 
The primary disadvantage of disk diffusion susceptibility testing is that, it provides a 
qualitative result, but a quantitative result indicating the degree of susceptibility may be 
desirable in most of the cases (Murray and others 2005). 
 
2.5.2 Interpretation 
The qualitative results of the antibacterial susceptibility tests may be reported with 
appropriate corresponding interpretative categories, including susceptible, intermediate 
and resistant (Watase and others 2011). 
Susceptible: The isolates are inhibited by the usually achievable concentrations of 
antimicrobial agent when the recommended dosage is used for the site of infection (CLSI 
2011). 
Intermediate: The isolate may be inhibited by attainable concentrations of certain drugs 
and/or compounds, if higher dosages can be used. It also implies clinical efficacy in body 
sites where the drugs are physiologically concentrated (e.g. quinolones and beta-lactams 
in urine) (CLSI 2011).  
Resistant: The isolates are not inhibited by the usually achievable concentrations of the 
antimicrobial agent with the normal dosage schedules, and/or that yield results that fall 
within a range where specific microbial resistance mechanisms are likely (CLSI 2011), 
and clinical efficacy of the agent against the isolate has not been reliably shown in 
treatment studies (Howard and others 1987).  
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2.5.3 Quality Control 
Quality control recommendations are designed to effectively evaluate the precision and 
accuracy of the dilutions and test procedures used, monitor reagent reliability, and 
evaluate the performance of individuals who are conducting the tests. Appropriate 
controls, depending on genera, must be included with every batch of MIC determinations. 
The tests should be performed under standardized conditions so that the results are 
reproducible. 
 
2.6 Minimum Inhibitory Concentrations of Natural Compounds 
The MIC is defined as the lowest concentration of a drug/compound that will inhibit the 
visible growth of an organism in vitro after overnight incubation (this period is extended 
for organisms such as anaerobes, which require prolonged incubation for growth). 
Minimum inhibitory concentrations (MICs) are considered the “gold standard” for 
determining the susceptibility of organisms to antimicrobials and are therefore used to 
judge the performance of all other methods of susceptibility testing.  Minimum inhibitory 
concentrations are important in diagnostic laboratories to confirm resistance of 
microorganisms to an antimicrobial agent, to give a definitive answer when a borderline 
result is obtained by other methods of testing, and also to monitor the activity of new 
antimicrobial agents (Barros and others 2007). An MIC is generally regarded as the most 
basic laboratory measurement of the activity of an antimicrobial agent against an 
organism.  
Clinically, the minimum inhibitory concentrations are used not only to determine the 
amount of antibiotic that the patient will receive but also the type of antibiotic used, 
which in turn lowers the opportunity for microbial resistance to specific antimicrobial 
agents (European Comm. Antimicrobial 2000). Using the MIC data, the dosage of 
antibiotics/atimicrobials may be refined. The MIC result is used in conjunction with 
therapeutic dosing information to select the most appropriate antimicrobial agent (Watase 
and others 2011). 
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In recent years, MICs have been used in Phytotherapy, the use of plants for medical 
purposes, which is one of the oldest practices in the world. The traditional practice, based 
on empirical data, is considered as folk medicine and the approach based on scientific 
studies aims to extract and study active components from plants. The demands for natural 
remedies along with the natural food additives combine phytotherapy with scientific 
studies. Thus, determination of the MICs has become the main factor for the scientific 
studies regarding the feasibility of bioactive components of the plants in industry. 
The standard procedures for determination of MICs and MIC limits used by the 
microbiology laboratory for determining the qualitative interpretations are included either 
in Clinical and Laboratory Standards Institute or National Committee for Clinical 
Laboratory Standards.   
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Table 2.1. Estimated annual number of domestically acquired, foodborne illnesses, 
hospitalizations, and deaths due to 31 pathogens and unspecified agents transmitted 
through food in United States (adapted from CDC 2011). 
Foodborne 
Agents 
Estimated 
annual 
number of 
illnesses* 
% 
Estimated 
number of 
hospitalizations* 
% 
Estimated 
annual 
number of 
deaths* 
% 
31 known 
pathogens 
9.4 million 
(6.6-12.7 
million) 
20 55,961 (39,534-75,741) 44 
1,351 
(712-2,268) 44 
Unspecified 
agents 
38.4 
million 
(19.8-61.2 
million) 
80 71,878 (9,924-157,340) 56 
1,686 
(369-3,338) 56 
Total 
47.8 
million 
(28.7-71.1 
million) 
100 127,839 (62,529-215,562) 100 
3,037 
(1,492-
4,983) 
100 
*: 90% credible interval 
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Table 2.2. Top five pathogens contributing to domestically acquired foodborne 
illnesses (adapted from CDC 2011). 
Pathogen Estimated number of illnesses 90% Credible Interval % 
Norovirus 5,461,731 3,227,0778-8,309,480 58 
Salmonella, 
nontyphoidal 1,027,561 644,786-1,679,667 11 
Clostridium 
perfringens 965,958 192,316-2,483,309 10 
Campylobacter spp. 845,024 337,031-1,611,083 9 
Staphylococcus 
aureus 241,148 72,341-529,417 3 
Subtotal   91 
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Table 2.3. Top five pathogens contributing to domestically acquired foodborne 
illnesses resulting in hospitalization (adapted from CDC 2011). 
Pathogen Estimated number of hospitalizations 
90% Credible 
Interval % 
Salmonella, 
nontyphoidal 19,336 8,545-37,490 35 
Norovirus 14,663 8,097-23,323 26 
Campylobacter spp. 8,463 4,300-15,227 15 
Toxoplasma gondii 4,428 3,060-7,146 8 
E. coli (STEC) O157 2,138 549-4,614 4 
Subtotal   88 
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Table 2.4. Top five pathogens contributing to domestically acquired foodborne 
illnesses resulting in death (adapted from CDC 2011). 
 
Pathogen Estimated number of deaths 
90% 
Credible 
Interval 
% 
Salmonella, 
nontyphoidal 378 0-1,011 28 
Toxoplasma gondii 327 200-482 24 
Listeria 
monocytogenes 255 0-733 19 
Norovirus 149 84-237 11 
Campylobacter spp. 76 0-332 6 
Subtotal   88 
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Table 2.5. Phenolic compounds and their natural sources. 
Compound Source Reference 
Caffeic a. coffee beans, white grapes, olive, spinach (Askun and others 2009a) 
Capsaicin chili peppers (septa)  (Kachoosangi and others 2008)  
Chlorogenic a. coffee beans, cumin, bamboo, honeysuckle flower (Xia and others 2011a) 
Coumarin 
tonka beans, vanilla, sweet grass, 
strawberries, cherries, woodruff, 
apricots 
(Bettaieb and others; 
Maddox and others 2010)   
Curcumin turmeric, mustard (Bhawana and others 2011) 
Decanol strawberries, E. coli (Yu and others 2000; Jetti and others 2007)  
Ellagic a. berries, pomegranate, grape, walnut, pecan  (Duman and others 2009)  
(-) Epicatechin tea leaves, cacao beans, cinnamon stick  (Cueva and others 2010) 
Eugenol cinnamon, clove, nutmeg, bay leaf, basil   (Singh and others 2008) 
Gallic a. grapes, gallnuts, sumac, tea leaves, hops, oak bark 
(Rivero-Cruz 2008; 
Bancirova 2010)   
Myricetin berries, grapes, walnuts (Yao and others 2011) 
Naringenin grapefruits, oranges (Erlund 2004; Vikram and others 2010)   
p-Coumaric a. peanuts, tomatoes, carrots, garlic  (Acar and others 2010)  
Quercetin onions, skins of apples, citrus fruits, cherries, fennel 
 (Geoghegan and others 
2010) 
Rosmarinic a. rosemary leaves and flowers, thyme  (Moreno and others 2006)   
Rutin asparagus, brake fern, citrus fruits, buckwheat (Pereira and others 2007a)  
Syringic a. acai palm trees, swiss chard, corn    (Korukluoglu and others; Kosina and others 2010) 
Tannic a. berries, nettle, tea leaves, sumac leaves, oak wood, chestnut, gallnuts  (Taguri and others 2004)  
Thymol thyme, nigella  seeds (black cumin) (Emiroglu and others 2010) 
Thymoquinine nigella seeds (black cumin) (Salem 2005; Tanis and others 2009)  
Xanthohumol female hops flowers, dandelion, marigold (Zanoli and Zavatti 2008) 
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Quercetin  C15H10O7 Myricetin   C15H10O8 Rutin  C27H30O16 
 
 
 
 
 
 
 
  
Coumarin  C9H6O2 Xanthohumol   C21H22O5 (-) Epicatechin C15H14O6 
 
 
 
 
 
Ellagic acid  C14H6O8 Eugenol  C10H12O2 Gallic acid  C7H6O5 
 
   
Chlorogenic a.  C16H18O9 Thymoquinine  C10H12O2 Thymol  C10H14O 
 
Figure 2.1. Chemical structures of some commonly used natural phenolic compounds. 
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Capsaicin   C18H27NO3 Curcumin  C21H20O6 
 
 
 
 
 
Rosmarinic acid  C18H16O8 Decanol  C10H22O 
  
Naringenin  C15H12O5  Caffeic acid  C9H8O4 
 
Tannic acid  C76H52O46 
 
Figure 2.1. continues 
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Figure 2.2. Mechanisms of action of organic acids in a bacterial cell (a-e). The left figure 
illustrates how the organic acids can pass through the outer membrane in Gram-negative 
bacteria, whereas the right figure shows how they can pass through the inner membrane 
in Gram-positive bacteria. Adapted from Raybaudi-Massilia and others 2009. 
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Figure 2.3. Mechanisms of action of essential oils and their components in a bacterial 
cell (a-f). Illustrates the mode of action at the inner membrane. Adapted from Burt 2004a.  
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Figure 2.4. Mechanism of action of nisin in a bacterial cell (a-b). Adapted from 
Raybaudi-Massilia and others 2009. 
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CHAPTER 3 
MATERIALS AND METHODS 
3.1 Preparation of Phenolic Compounds 
Several types of natural phenolic compounds extracted from herbs, spices, vegetables, 
and fruits are used for this study. Capsaicin, Chlorogenic acid, Coumarin, Decanol, 
Ellagic acid, (-) Epicatechin, Myricetin, Quercetin,  Rutin, Tannic acid,  Curcumin, 
Eugenol, Gallic acid, Rosmarinic acid, Thymol, Thymoquinine, and Xanthohumol were 
obtained from Sigma-Aldrich Group and stored at optimum temperature and conditions 
required for each compound. 
Four different concentrations; 5, 10, 15 and 20 parts per million (ppm) of each compound 
were prepared in appropriate solvents including; Ethanol, 190 proof (95%) (Decon 
Laboratories, Inc.), Propylene glycol (Fisher Scientific), Dimethyl sulfoxide (DMSO) 
(Fisher Scientific), and ionized H2O according to the National Committee for Clinical 
Laboratory Standards (NCCLS 1994). Some of the solutions were heated up in a steamer 
(Wilmot Castle Sterogage, Co., NY, USA) including quercetin, ellagic acid, and 
xanthohumol, to obtain complete dissociation of the compound in the solvent. pH 
analysis was performed with an electronic pH meter (Accumet Basic AB15, Fisher 
Scientific, Fairlawn, NJ). For accurate pH measurement, pH meter was standardized 
through the use of pH=4.01 and pH=6.86 standard buffer solutions. The final phenolic 
solution was adjusted to approximately pH=5.00 to ensure the pH would not affect the 
bacterial growth. All solutions were filter sterilized using 0.2 µm filters (Millipore 
Corporation). The filter sterilized solutions were stored at 4°C in sterilized glass sealed 
containers until needed. All solutions were allowed to come to room temperature prior to 
use. 
 
3.2 Bacterial Strains, Culture Conditions and Preparation of Inoculum 
Three different strains of pathogenic Salmonella spp., E. coli, Bacillus spp., Listeria 
monocytogenes and Clostridium spp. were supplied from the American Type Culture 
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Collection (ATCC 6051, Difco Spores, ATCC 842, ATCC 7644, UK Animal Diagnostic 
Lab., ATCC 49594, R. Newsome Research, ATCC 8260, ATCC 7955, F. T. Jones, 
ATCC 43895, ATCC 35150, UK Micro 29A, ATCC 10708, and (-) H2S). In this study, 
they were evaluated to determine the minimum inhibitory concentration (MIC) of several 
natural compounds. 
Aerobic bacteria cells were grown and maintained on slants of brain-heart infusion (BHI) 
agar, (Difco Laboratories, Becton Dickinson and Company, USA) and stored at 4°C until 
needed. Anaerobic bacteria cells including Clostridium species were grown and 
maintained in Thioglycollate Medium (Difco, Becton, Dickinson and Company, USA) 
under anaerobic conditions and stored at 4°C until needed. Thioglycollate broth was 
steamed for about 15 minutes to drive off the oxygen from the media prior to each 
use.Prior to each study at least three consecutive transfers of the aerobic bacterial cultures 
were inoculated in BHI broth, (Difco Laboratories, Becton, Dickinson and Company) and 
anaerobic cultures were performed in Differential Reinforced Clostridial (RC) Media 
(Difco Laboratories, Becton, Dickinson and Company, USA) under anaerobic conditions. 
Incubation for Clostridium was grown in GasPak jars (GasPak Anaerobic System, BBL, 
BioQuest) along with O2 scavenger BD GasPak Ez Anaerobic Container System (Becton, 
Dickinson and Company, Maryland, USA) to maintain the anaerobic conditions. Prior to 
each use, RC broth was steamed for about 15 minutes to drive off the oxygen and rapidly 
cooled. The cultures were incubated overnight at optimal temperatures for each 
bacterium. With most bacteria, an overnight incubation period is sufficient, but an 
additional day may be needed for the more slowly growing microorganisms, such as 
Clostridium. After a sufficient period of incubation, the inoculums were standardized 
according to a MacFarland 0.5 turbidity standard (108 CFU/ml) by diluting the sample 
(National Committee for Clinical Laboratory Standards, NCCLS, 2004). Culture growth 
turbidity, which indicated by the Optical Density (OD), was adjusted to a specific rate for 
each type of bacteria at a wavelength of 660 nm (OD660), using the spectrophotometer, 
(BioTek Synergy 4) to the final concentrations of approximately 107-108 CFU/ml. After 
the culture growth, turbidity has been adjusted to a specific OD regarding the bacteria. 
For E. coli turbidity was adjusted to 0.02 OD whereas, it was 0.2 for Listeria 
monocytogenes and Salmonella. Direct culture was used without adjusting the optical 
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density for Bacillus and Clostridium. Once diluted, suspension of the inoculums was 
tested within 20-30 minutes.  Cell counts were confirmed using a spiral plating method. 
Serial dilutions (10-3 and 10-4) of the bacterial cultures were plated onto Plate Count Agar 
(PCA), (Difco Laboratories, Becton, Dickinson and Company) with the Eddy Jet spiral 
plater (IUL Instruments, Neutec Group Inc.) and incubated for 24 to 48 hours at 
appropriate incubation conditions for each type of bacteria. The bacterial counts were 
determined by the Flash and Go plate reader (IUL Instruments, Neutec Group Inc.). 
Table 3.1 shows the optical density of initial inoculums, initial bacterial cell counts of 
PCA plates, and the incubation conditions for each of the bacterial strain used in this 
study.  
 
3.3 Screening for Antimicrobial Activity 
Micro broth dilution technique of Antimicrobial Susceptibility testing is employed as 
outlined in the NCCLS.  
Procedure for Aerobic Organisms: 
Five ml of Mueller Hinton Broth (MHB) (Difco Laboratories, Becton, Dickinson and 
Company) dispensed into each test tube and sterilized in the scientific gravity sterilizer 
(STERIS AMSCO Century, SG-120, Thermo Scientific). One hundred µl of each serial 
solution of the compounds were dispensed into each 5 ml MHB, to obtain the final 
concentrations of 5, 10, 15 and 20 ppm (µg/L). Then, 100 µl of the overnight culture (at 
least three consecutive transfers) of each bacterial strain was transferred aseptically into 
each MHB tube containing the specific amount of compound. Three controls were used. 
First, a compound and culture free, pure un-inoculated MHB was used as a blank for 
sterility check and adjusting the spectrophotometer. Then a compound free MHB broth 
(growth control), including only culture, was used as a positive control. Finally, a 
negative control in which 100 µl of the solvent, either ethanol, ionized H2O, propylene 
glycol, or DMSO was dispensed in 5 ml of MHB, in order to determine the possible 
effect of the solvent on the bacterial growth performance. One hundred and fifteen µl of 
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each sample, including the blank, positive and negative controls, was dispensed to each 
well of a 96-well flat bottom micro-titer plate (Nalge NUNC Int., NY, USA). The final 
assay volume was 150 µl. The serial concentrations of phenolic compounds were 
adjusted to a final assay volume of 150 µl: 3 µl of positive or negative control solutions 
plus 147 µl of the diluted strain; 3 µl of phenolic compound solution plus 147 µl of the 
diluted strain. All treatments were carried out in duplicates for each individual strain. 
After inoculation, the micro-titer plates were read immediately using a calibrated 
spectrophotometer (BioTek Synergy 4) at 660 nm wavelength. After getting the initial 
OD, the micro-titer plates were incubated at optimal temperatures for each bacterial 
strain. Prior to each incubation process, the samples in the micro-titer plate were shaken 
for 10 seconds to get a consistent homogeneity. The absorbance was read at every 12-
hour intervals of total 60 hours of incubation period. 
Procedure for Anaerobic Organisms: 
Five ml of RC Media was dispensed into sterilized 10 ml serum bottles (Fisher Scientific) 
and covered with aluminum foil. They were autoclaved and cooled for 10-15 minutes. 
The oxygen free serum bottles were covered with appropriate sterile plastic stoppers 
(Fisher Scientific) and sealed air tight with aluminum caps (Fisher Scientific) to maintain 
anaerobic conditions. 
One hundred µl of each serial solution of the compounds were released via a 1 ml syringe 
(Fisher Scientific) into each 5 ml RC media, to obtain the final concentrations of 5, 10, 15 
and 20 ppm (µg/L). Then, 100 µl of the overnight culture (at least three consecutive 
transfers) of each bacterial strain was transferred via a syringe into each RC media serum 
bottle containing the specific amount of compound. Three controls were used. First, a 
compound and culture free, pure un-inoculated RC media was used as a blank for sterility 
check and adjusting the spectrophotometer. Then a compound free RC media (growth 
control), including only the culture, was used as a positive control. Finally, a negative 
control in which 100 µl of the solvent, either ethanol, ionized H2O, propylene glycol, or 
DMSO was released in 5 ml of RC media, in order to determine the possible effect of the 
solvent on the bacterial growth performance. One hundred and fifteen µl of each sample, 
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including the blank, positive and negative controls, was dispensed into each well of a 96-
well flat bottom micro-titer plate (Nalge NUNC Int., NY, USA). The final assay volume 
was 150 µl. The serial concentrations of phenolic compounds were adjusted to a final 
assay volume of 150 µl: 3 µl of positive or negative control solutions plus 147 µl of the 
diluted strain; 3 µl of phenolic compound solution plus 147 µl of the diluted strain. All 
treatments were carried out in duplicates for each individual strain. 
After inoculation, the micro-titer plates were read immediately using a calibrated 
spectrophotometer (BioTek Synergy 4) at 660 nm wavelength. In order to maintain the 
anaerobic conditions for Clostridium serum bottles were incubated and kept in the 37⁰C 
incubator during the 60 hours of incubation period. After getting the initial OD, the 
micro-titer plates were discarded. Prior to each screening process samples from the 
incubated RC media were taken via a syringe and then, dispensed into the micro-titer 
plates. Prior to each screening process, the samples in the micro-titer plate were shaken 
for 10 seconds to get a consistent homogeneity. Absorbance was read at 12-hour intervals 
over 60 hours of incubation. All of the micro-titer plates were discarded immediately 
after the screening process. 
The same procedures were employed for all the compounds tested in this study. The 
experiments were conducted in two replicates for each individual strain. 
 
3.4 Determination of Minimum Inhibitory Concentrations of Phenolic Compounds 
There are various in vitro techniques to test minimum inhibitory concentrations to 
determine antimicrobial susceptibility or resistance of individual isolates. The goal of our 
study was to determine whether the etiologic agent is resistant or sensitive to the natural 
antimicrobial agents being tested.  
MIC, being the lowest concentration that inhibits visible growth of the organism was 
determined according to 90 % inhibition level. The antimicrobial agent has to inhibit 90 
% of the visible microbial growth to be considered as the MIC of the antimicrobial agent 
against the organism used.  Thus, the tested organism was called “susceptible (sensitive)” 
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to the natural antimicrobial agent used. However, when the microbial growth was not 
inhibited 90 %, then the organism tested was called “resistant” to the natural 
antimicrobial agent used (NCCLS 2004). Turbidity was compared between the control 
well and the test wells. 
Formula: 
MIC= [OD Control after incubation - OD Blank] x 90% > [OD Treatment after 
incubation - OD Blank] 
The minimum concentration (ppm) of the natural antimicrobial compound tested, which 
showed less growth than 90% of the control regarding the specific bacteria was recorded 
as the MIC. 
 
3.5 Investigation of Structural Changes via Scanning Electron Microscopy 
3.5.1 Materials and Sample Preparation 
Treated and non-treated (control) bacterial cultures were incubated for 24 hours at 
appropriate conditions for the type of bacteria. Then, they are diluted to 10-4 and/or 10-6 
concentrations and filtered using sterilized 0.2 µm filters (Thermo Scientific, Nalgene, 
Analytical Filter, CN) to capture the bacteria for Scanning Electron Microscope (SEM) 
observations. Every specimen destined for conventional SEM must be dry. As living 
microorganisms, bacteria contain proteins and a high amount of water in their cells. It is 
essential to fix them to micro filters in order to preserve their structure. To prepare the 
samples in reasonable time, the specimens should be relatively thin (<2 mm) and only a 
few millimeters in dimensions (Kalab and others 2009). Large solid materials which 
contain bacteria on their surfaces such as contaminated meat, skin, vegetables, composted 
materials, or agar gel plates with bacterial colonies are first excised and trimmed to 
approximately 10 mm x 10 mm x 2 mm in dimensions and fixed before they are further 
reduced into smaller (approx. 5 mm x 5 mm x 2mm) particles.  
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Glutaraldehyde-Phosphate Buffer Preparation: 
Pure 50 % solution of Glutaraldehyde reagent (E.M. Grade, SPI Supplies, Structure 
Probe, Inc., USA) was prepared with Sodium Phosphate Monobasic (Na2HPO4, 
Anhydrous, Fisher Scientific), to 6 % of final concentration. 
       12 ml 50 % pure Glutaraldehyde 
       44 ml Na2HPO4 (0.1 M, pH 7.0) 
+     44 ml ionized H2O 
      100 ml Glutaraldehyde fixative (6%) 
The filters containing thin layers of bacterial specimens were soaked in the buffered 
fixative, glutaraldehyde (6 %) for a minimum of1 hour. 
Fixed specimens were submerged in ionized H2O and dehydrated for 5-10 minutes by 
soaking in serial dilutions of ethanol including; 20 %, 40 %, 60 %, 80 %, and 100 %, 
respectively. 
5-10 minutes in 20 % Ethyl alcohol 
5-10 minutes in 40 % Ethyl alcohol 
5-10 minutes in 60 % Ethyl alcohol 
5-10 minutes in 80 % Ethyl alcohol 
5-10 minutes in 100 % Ethyl alcohol 
5-10 minutes in 100 % Ethyl alcohol 
For critical point drying, the dehydrated specimens were submerged in 
hexamethyldisilazane (HMDS, Sigma-Aldrich, USA) for 5 minutes. Then, the specimens 
were air dried under the fume hood. 
The double sided adhesive conductive carbon tabs (SPI Supplies, Structure Probe, Inc., 
PA, USA) were placed over the specimen stubs (SPI Supplies, Structure Probe, Inc., PA, 
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USA). Double sided sticky tape on the face of a SEM stub facilitates the specimens’ 
(filters with bacteria on top) positioning. Then, the specimens were cut in appropriate 
sizes and mounted over the carbon tabs. They were left at the desiccators overnight. 
Specimens can be kept at desiccators for several weeks prior to SEM observation. 
Specimens were prepared in two replicates for each individual strain. 
Coating the Specimens: 
Fixed and dried specimens were sputter-coated with Carbon using a plasma coating 
system for SEM (Hummer VI, Sputtering System by Technics). They acquire electrically 
conductive surfaces after they are sputter-coated to be examined efficiently by SEM. 
 
3.5.2 Capturing Images with Scanning Electron Microscope 
The specimens were examined on a Scanning Electron Microscope (SEM S-800, Hitachi, 
Tokyo, Japan) operated at 10-20 kV accelerating voltage. Magnification and working 
distance were adjusted for the position and type of specimen. The captured images were 
analyzed using the software Evex Nanoanalysis and Digital Imaging (Evex Analytical 
Version 2.0.1192, 2006). 
 
3.6 Statistical Analysis 
The antimicrobial activity of the phenolic compounds was subjected to General Linear 
Model procedure of Statistix 9.0(2008). Significance level of P <0.05 of the null 
hypothesis was used to determine significant variables. Difference between means was 
identified by use of Tukey HSD randomized complete block design between treatments 
and time.
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Table 3.1. Initial bacterial inoculums and bacterial cell counts, and the incubation 
temperatures. 
Bacteria Initial Count (CFU/ml) 
Initial Inoculum 
(OD) 
Incubation 
Temperature (⁰C) 
Bacillus subtilis              
ATCC 6051 6.025 x 10
8 
Direct culture 32⁰C Bacillus cereus               Difco Spores  8.465 x 10
7 
Bacillus polymyxa        
ATCC 842 3.975 x 10
8 
Listeria monocytogenes 
ATCC 7644 1.985 x 10
8 
0.2 37⁰C Listeria monocytogenes UK Animal Diag. Lab. 2.725 x 10
8 
Listeria monocytogenes 
ATCC 49594 4.270 x 108 
Clostridium perfringens   
R. Newsome Research 1.590 x 10
7 
Direct culture 37⁰C Clostridium butyricum ATCC 8260 1.040 x 10
7 
Clostridium sporogenes 
ATCC 7955 1.000 x 10
7 
Escherichia coli                     
F. T. Jones 3.490 x 10
7 
0.02 37⁰C Escherichia coli O157:H7 ATCC 43895 6.165 x 10
7 
Escherichia coli 
O157:H7 ATCC 35150 2.315 x 10
7 
Salmonella paratyphi 
UK Micro 29A 1.090 x 10
8 
0.2 37⁰C Salmonella cholerasuis subsp. ATCC 10708 1.335 x 10
8 
Salmonella enteridis            
(-) H2S 
1. 130 x 108 
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CHAPTER 4 
Minimum Inhibitory Concentrations of Natural Antimicrobial Phenolic Compounds 
Derived from Herbs & Spices 
4.1 Introduction 
In recent years, consumers have increasing concerns about the food safety to prevent and 
control pathogenic microorganisms in food, leading to many attempts to use natural 
substances of plant origin. Spices and aromatic herbs have long been used in food for not 
only their flavor but also for their preservative and medicinal properties (Shan and others 
2007a). Many herb and spice extracts possess antimicrobial activities against a wide 
range of bacteria, yeasts, and molds (Shan and others 2007a; Raybaudi-Massilia and 
others 2009). Since the ancient times, these have been used throughout the world for 
preventing food spoilage and deterioration and also for extending shelf life of foods, 
while attempts to characterize these properties in the laboratory date back to the early 
1900s.  
Recent research studies revealed that active compounds such as thymol (obtained from 
thyme) and eugenol (obtained from cinnamon and clove) disrupts the cellular membrane, 
eventually causing the death of several microorganisms such as E. coli, E. coli O157:H7, 
L. monocytogenes, and Salmonella enteridis (Raybaudi-Massilia and others 2009). 
Eugenol was found to inactivate the pathogenic microorganisms including; E. coli 
O157:H7 and L. monocytogenes with 4 to 6 log CFU/ml reductions when applied in 
pasteurized apple juice. Dorman and Deans (2000) reported that thymol has greater 
inhibitory activity against Gram-positive organisms such as Bacillus subtilis and 
Clostridium sporogenes. Moreno and others (2006) determined the antimicrobial activity 
of rosmarinic acid which showed inhibitory activity for neither E. coli nor B. subtilis. 
Xanthohumol reported to be highly effective against Gram-positive and some certain 
Gram-negative bacteria (Natarajan and others 2008). Some clinical in vitro studies 
suggest that xanthohumol has a potential antibacterial, antifungal, and chemo-preventive 
activity (Zanoli and Zavatti 2008).  
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The purpose of this study was to determine the antimicrobial activity and the MIC of the 
phenolic compounds derived from herbs and spices for both Gram-positive and Gram-
negative foodborne pathogens. Antimicrobial Susceptibility Testing Method was 
employed to investigate inhibition and control the growth of aerobic foodborne pathogens 
in Mueller Hinton Broth and anaerobic pathogens in Reinforced Clostridial Broth. 
 
4.2 Results and Discussion 
Antimicrobial characteristics of phenolic compounds obtained from herbs and spices, 
including curcumin, eugenol, gallic acid, rosmarinic acid, thymol, thymoquinine, and 
xanthohumol were investigated against foodborne pathogens (NCCLS 2004). The 
phenolic compounds were found to be effective for inhibiting the growth of various 
Gram-positive bacterial species including Bacillus (Table 4.1), Listeria monocytogenes 
(Table 4.2), Clostridium (Table 4.3), and Gram-negative bacteria such as Escherichia coli 
(Table 4.4) and Salmonella species (Table 4.5). 
Curcumin  
The results of this study for B. subtilis ATCC 6051 (Appendix Figure 1) are consistent 
with the previous studies done with curcumin, which is found to be antimicrobial 
(Bhawana and others 2011). Inhibition of B. subtilis Difco Spores was observed at 24 
hours at higher concentrations of curcumin (15 ppm). B. cereus (Figure 4.1) and B. 
polymyxa ATCC 842 (Figure 4.2) showed high sensitivity with the MICs of 15 and 
5ppm, respectively. After 24 hours of incubation they recovered. 
Curcumin showed no antimicrobial activity against L. monocytogenes ATCC 7644 
(LM1) and L. monocytogenes UK Animal Diagnostic Lab. (UK ADL (LM3)), which 
were observed to be highly resistant. However, it relatively inhibited the growth of L. 
monocytogenes ATCC 49594 (LM2) (Figure 4.3) after 60 hours of incubation, where the 
MIC of curcumin was determined to be 20 ppm. 
All three strains of Clostridium, C. perfringens R. Newsome Research (RNR (C1)), C. 
butyricum ATCC 8260 (C2), and C. sporogenes ATCC 7955 (C3) were observed to have 
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relatively close antimicrobial sensitivity when tested with curcumin, with the MICs of 5 
ppm following 60 hours of incubation. The Figure 4.4 shows the average of antimicrobial 
activities of curcumin when tested against those three strains of Clostridium. 
Curcumin has been previously observed to have antimicrobial activity against E. coli 
species (Bhawana and others 2011). E. coli O157:H7 ATCC 43895 (EC2) showed no 
antimicrobial activity with curcumin exposure during the entire 60 hours of incubation 
period. We showed varying degrees of antimicrobial activity against non-pathogenic E. 
coli F. T. Jones (FTJ (EC1)) (Figure 4.5), and E. coli O157:H7 ATCC 35150 (EC3) 
(Appendix Figure 2) with MICs of <20 ppm.  
S. paratyphi UK Micro 29A (S1) (Appendix Figure 3), S. cholerasuis subsp. ATCC 
10708 (S2) (Figure 4.6) and S. enteridis (-) H2S (S3) (Appendix Figure 4) were observed 
to be sensitive against curcumin after 60 hours of incubation. The MIC of curcumin was 
determined as <20 ppm for those species of Salmonella. Also, S. cholerasuis subsp. 
demonstrated the highest antimicrobial sensitivity during the entire incubation period.   
Eugenol 
MIC of eugenol was determined to be 15 ppm when tested against B. cereus following 60 
hours of incubation time (Figure 4.8). B. subtilis (Figure 4.7) and B. polymyxa (Appendix 
Figure 5) showed a similar antimicrobial activity with MIC of 20 ppm, immediately 
following exposure. However B. subtilis recovered resistance against eugenol following 
36 hours of incubation. Previous studies also denote eugenol being effective against 
inhibiting the growth of B. subtilis (Saei-Dehkordi and others 2010). 
Eugenol was observed to have a high antimicrobial activity when it was tested against 
LM1 (Appendix Figure 6), LM2 (Appendix Figure 7) and LM3 (Appendix Figure 8). 
MICs of eugenol against those L. monocytogenes strains were determined to be <10 ppm 
after 60 hours of incubation period.  To some extent this was consistent with previous 
studies on antibacterial activity of eugenol, which was found to be effective to inhibit the 
growth of L. monocytogenes after being incorporated into alginate-based edible coatings 
(Raybaudi-Massilia and others 2009). Eugenol, extracted from clove, was also reported 
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being highly effective in reducing the proliferation of L. monocytogenes on the surface of 
fresh lettuce (Kim and others 2011). 
C. butyricum and C. sporogenes were observed to be highly resistant against eugenol 
during the entire 60 hour incubation period. However, C. perfringens (Figure 4.9) was 
determined to be sensitive to <20 ppm eugenol, following 60 hours of incubation. 
All E. coli strains tested with eugenol were observed to have high degrees of 
antimicrobial activity following 60 hours of incubation, with resulting MICs of 20 ppm. 
The average antimicrobial activities of the three strains of EC1, EC2, and EC3 were 
shown in Figure 4.10. These eugenol results were also consistent with previous studies, 
where eugenol was found to be highly antimicrobial against E. coli after being 
incorporated into alginate-based edible coatings (Raybaudi-Massilia and others 2009). In 
vitro studies of E. coli O157:H7 also confirmed eugenol’s high antimicrobial activity 
(Saei-Dehkordi and others 2010). According to Kim and others (2011) eugenol, from 
clove found to be highly effective against reducing the population of E. coli O157:H7 on 
the surface of fresh lettuce. 
Eugenol was observed to be very effective against inhibiting the growth of Salmonella 
species during 60 hours of incubation. Previous studies confirm these results, where 
eugenol was found to be highly effective in reducing the population of Salmonella 
species on fresh lettuce (Kim and others 2011). The MICs of eugenol against S. paratyphi 
(Appendix Figure 9), S. cholerasuis subsp. (Figure 4.11) and S. enteridis (Figure 4.12) 
were determined as 15 ppm, after 60 hours. 
Gallic acid  
Both B. cereus and B. polymyxa were highly resistance against gallic acid. Previous 
studies reported B. cereus isolates to be sensitive to gallic acid (Askun and others 2009a). 
On the other hand, MIC of B. subtilis (Figure 4.13) was determined to be 10 ppm during 
the entire 60 hours of incubation. 
Gallic acid was observed to be effective in inhibiting the growth of LM2 (Appendix 
Figure 10) and LM3 (Appendix Figure 11) following 60 hours of incubation, with MIC 
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of <10 ppm. However, LM1 showed a very high resistance against gallic acid during the 
entire 60 hours of incubation period.  
When treated with gallic acid, all three strains of Clostridium were observed to be very 
sensitive, having similar antimicrobial activities after the incubation period of 60 hours. 
Figure 4.14 shows the average antimicrobial activity of   C. perfringens, C. butyricum 
and C. sporogenes. The MIC of gallic acid was determined as 5 ppm for all of the three 
strains of Clostridium.  
Gallic acid was reported to be highly antimicrobial against Gram-negative pathogens 
(Askun and others 2009a) including the phytopathogen Xylella fastidiosa (Maddox and 
others 2010). All of the three strains of E. coli were observed to have very similar 
antimicrobial activity against gallic acid, with MIC of 15, after 60 hours of incubation. 
Figure 4.15 shows the average degrees of antimicrobial sensitivity of EC1, EC2, and 
EC3. 
Salmonella species tested against gallic acid were observed to have varying degrees of 
antimicrobial activity. S. paratyphi (Appendix Figure 12) was determined to be sensitive 
until 36 hours of incubation period and then, it became resistant at 15 ppm. S. enteridis 
(Figure 4.16) showed a similar antimicrobial sensitivity after 60 hours of incubation 
when treated with gallic acid at 15 ppm. However, S. cholerasuis subsp. was observed to 
be highly resistant when treated and incubated with gallic acid. 
Rosmarinic acid 
All three strains of Bacillus showed varying degrees of antimicrobial sensitivity when 
they were treated and incubated with rosmarinic acid for 60 hours. B. cereus 
demonstrated high antimicrobial susceptibility confirming the previous reported results 
with rosmarinic acid (Askun and others 2009a). MICs were determined for B. subtilis 
(Appendix Figure 13), B. cereus (Figure 4.17), and B. polymyxa (Appendix Figure 14) as 
5, 10, and 15 ppm, respectively. The previous studies show that rosmarinic acid did not 
inhibit the growth of B. subtilis (Moreno and others 2006). However, in this study, B. 
subtilis was found to be highly sensitive against rosmarinic acid.  
53 
 
Rosmarinic acid was observed to have no antimicrobial activity against Listeria 
monocytogenes strains tested, LM1, LM2, and LM3, during the 60 hour incubation 
period.  
C. butyricum (Figure 4.18) and C. sporogenes (Figure 4.19) tested against rosmarinic 
acid were determined to have a very similar sensitivity, with MICs of <20 ppm, but with 
different incubation times. C. butyricum showed consistent antimicrobial sensitivity until 
the end of 60 hours incubation, while C. sporogenes regained its resistance after 48 
hours. However, rosmarinic acid was found not to be effective against inhibiting the 
growth of C. perfringens. 
Gram-negative pathogens were previously reported to be highly susceptible to rosmarinic 
acid (Askun and others 2009a). Distinctly, in this study E. coli strains EC1, EC2, and 
EC3 were observed to be highly resistant to rosmarinic acid during the 60 hours of 
incubation. Therefore these findings validated that the previous studies on effectiveness 
of rosmarinic acid on E. coli are inconsistent (Moreno and others 2006). 
Salmonella species were observed to have high degrees of antimicrobial sensitivity when 
treated with rosmarinic acid. The MICs of rosmarinic acid for S. paratyphi (Figure 4.20), 
S. cholerasuis subsp. (Figure 4.21) and S. enteridis (Appendix Figure 15) were 
determined as <20 ppm after the 60 hours of incubation.  
Thymol  
All of the three strains of Bacillus were highly sensitive to thymol after 60 hours 
incubation. B. subtilis was previously reported to be highly susceptible to thymol (Salem 
2005; Saei-Dehkordi and others 2010). MIC of thymol was determined as <20 ppm 
against B. subtilis (Appendix Figure 16), B. cereus (Figure 4.22) and B. polymyxa (Figure 
4.23). Consistently, previous reports also show the susceptibility of B. cereus to thymol at 
25 mg/ml (Tanis and others 2009).  
Thymol was previously reported to have antimicrobial activity against Listeria (Tanis and 
others 2009). However in this study, thymol was observed to have no antimicrobial 
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activity against L. monocytogenes strains tested, LM1, LM2, and LM3, during the 60 
hours of incubation period.  
The three strains of Clostridium, C. perfringens, C. butyricum, and C. sporogenes tested 
against thymol were determined to have very similar sensitivity, with MIC of 5 ppm 
following 60 hours of incubation time. Figure 4.24 shows the average antimicrobial 
activity of thymol against the Clostridium species tested. 
Thymol was previously reported to not have antimicrobial activity against E. coli, when 
suspended with H2O (Bakathir and Abbas 2011). In this study, thymol concentration with 
ethanol was used and a consistent antimicrobial activity was observed among the three 
treated strains of E. coli, following 60 hours of incubation period. Previous reports are 
inconsistent with the results of this study for E. coli O157:H7 being highly susceptible to 
thymol (Saei-Dehkordi and others 2010). The MIC was determined as 15 ppm and Figure 
4.25 shows the average antimicrobial activity of EC1, EC2, and EC3 together. 
 S. paratyphi (Appendix Figure 17) and S. cholerasuis subsp. (Appendix Figure 18) were 
observed to be sensitive against thymol, with the MIC of 15 ppm following 60 hours of 
incubation period. However, S. enteridis was found to be consistently resistant to thymol 
during the entire incubation period. 
Thymoquinine  
Bacillus species were found to have varying degrees of antimicrobial sensitivity during 
the whole 60 hours of incubation period, when tested against thymoquinine. Previous 
studies reported thymoquinine to be effective against several Bacillus species (Salem 
2005; Salem and Hossain 2000) including B. cereus (Tanis and others 2009) with MIC of 
<27 mm in diameter (highly active). MICs of B. subtilis (Appendix Figure 19), B. cereus 
(Figure 4.26), and B. polymyxa (Appendix Figure 20) were determined as <15 ppm.  
Thymoquinine was observed to have a consistent antimicrobial activity among all the 
three strains of L. monocytogenes, which are consistent with previous Listeria studies 
with thymoquinine (Tanis and others 2009). The MIC for all strains was determined as 10 
ppm. Appendix Figure 21 shows the average antimicrobial activity of LM1, LM2, and 
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LM3. After 60 hours of incubation LM1 and LM3 were observed to be very sensitive, 
whereas LM2 became resistant to thymoquinine after being incubated for 12 hours. 
C. perfringens (Figure 4.27) and C. sporogenes (Figure 4.28) were observed to have 
similar antimicrobial sensitivity to thymoquinine during the entire incubation period. The 
MICs for C. perfringens and C. sporogenes were determined to be <10 ppm following 60 
hours of incubation.  
In previous studies, thymoquinine was not found to be effective against E. coli when 
suspended with H2O (Bakathir and Abbas 2011). However, in this study using ethanol as 
the diluents for thymoquinine was highly effective. It was determined to have a MIC of 
20 ppm against non-pathogenic EC1, EC2, and EC3 following 60 hours of incubation 
Figure 4.29 depicts the average of consistent antimicrobial activity for the three E. coli 
strains.  
S. paratyphi (Appendix Figure 22), S. cholerasuis subsp. (Figure 4.30) and S. enteridis 
(Figure 4.31) were observed to have a similar antimicrobial activity after being treated 
and incubated for 60 hours with thymoquinine. The MICs were determined as <20 ppm. 
Xanthohumol 
Xanthohumol was shown to have high antimicrobial activity against B. subtilis (Figure 
4.32), and B. polymyxa (Appendix Figure 4.23) when used at 5 ppm concentration. B. 
cereus (Figure 4.33) also showed antimicrobial sensitivity to Xanthohumol, with the MIC 
of 20 ppm at 60 hours of incubation.  
All three strains of Listeria were observed to be highly susceptible when treated with 
xanthohumol. MICs of LM1, LM2 and LM3 were determined as 5 ppm after 60 hours of 
incubation. Figure 4.34 depicts the average antimicrobial activity of xanthohumol against 
L. monocytogenes. 
Xanthohumol was determined to have consistently high antimicrobial activity against 
three species of Clostridium; C. perfringens, C. butyricum and C. sporogenes. MICs of 
those three strains were determined to be 5 ppm after 60 hours of incubation period. 
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Figure 4.35 depicts the average antimicrobial activity of xanthohumol against 
Clostridium species. 
Previous studies suggest that xanthohumol has no antimicrobial activity against E. coli 
(Zanoli and Zavatti 2008). Contrary, E. coli strains used in this study were found to have 
varying degrees of antimicrobial sensitivity during the 60 hour incubation period, when 
tested against xanthohumol.  EC1 (Figure 4.36) and EC2 (Appendix Figure 24) were 
observed to be sensitive when treated with xanthohumol, with concentrations of 15 ppm. 
EC3 showed high resistance during the whole incubation period.  
S. enteridis was found to be very resistant against xanthohumol, showing no growth 
inhibition during the 60 hours of incubation period. However, S. paratyphi (Appendix 
Figure 25) and S. cholerasuis subsps. (Appendix Figure 26) were observed to be 
sensitive, following 60 hours. MICs of xanthohumol for S. paratyphi and S. cholerasuis 
subsps. were determined as 20 and 15 ppm, respectively. 
 
4.3 Conclusion 
The results revealed that the tested phenolic compounds have varying antimicrobial 
effects against pathogenic bacteria. Generally, Gram-negative bacteria (E. coli and 
Salmonella) Gram-positives (Bacilli, Listeria monocytogenes, and Clostridium) were 
observed to have different degrees of antimicrobial susceptibility following 60 hours of 
incubation. These variations may reflect the differences in cell surface structures between 
Gram-negative and Gram-positive bacteria. In particular, the outer membrane of Gram-
negative bacteria functions as a preventive barrier against hydrophobic compounds 
(Puupponen-Pimia and others 2001). Some of the results were not consistent with 
previous studies on antibacterial activity of the bioactive compounds of cinnamon stick 
(Shan and others 2007a). The reason for that may be using different sources of phenolic 
compounds and/or different bacterial species, which affect the bacterial response to the 
antimicrobials. 
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Different strains of the same family showed varying degrees of antimicrobial 
susceptibility, with different concentrations of phenolic compounds. Thus, each phenolic 
compound had different MICs for each bacterial strain. Figure 4.6 and Figure 4.7 depict 
the summary of MICs of both Gram-positive and Gram-negative bacteria for 60 hours of 
incubation period. However, curcumin, gallic acid, thymol, and xanthohumol had the 
same MICs (<5 ppm) for all strains of Clostridium. Thymoquinine had MIC of 10 ppm 
for all strains of Listeria monocytogenes. Moreover, all three strains of E. coli, including 
non-pathogenic E. coli and E. coli O157:H7 showed consistent antimicrobial 
susceptibility against eugenol, gallic acid, thymol, and thymoquinine, with the MICs of 
20, 15, 15, and 20 ppm, respectively. 
Overall, thymoquinine was found to be the most effective phenolic compound against 
both Gram-positive and Gram-negative pathogens. The highest concentration of 
thymoquinine used for the antimicrobial affect was 20 ppm. The investigated strength of 
antimicrobial activity was followed by eugenol, xanthohumol, curcumin, gallic acid, 
rosmarinic acid and thymol, respectively. This study provides long term storage food 
safety results for foodborne pathogens. Previous studies only established MICs for 24 
hour incubation periods, while in this study, we determined the MICs after the incubation 
period of 60 hours. Thus, the antimicrobial affects of these natural phenolic compounds 
understood more efficiently when they are exposed to long term storage in food and food 
applications. We were also able to compare the antimicrobial activity of the phenolics 
between 24 hours and 60 hours of incubation. Table 4.8 and Table 4.9 depict the MICs of 
phenolics for both Gram-positive and Gram-negative pathogens after 24 hours of 
incubation. The results suggest that the sensitivity of the pathogenic bacteria to phenolic 
compounds depends on bacterial species and polyphenol structure of the phenolics. 
Incubation period is another factor affecting the bacterial growth, where some of the 
sensitive pathogens recover and become resistant after 24 hours of incubation. 
  
58 
 
Table 4.1. Minimum Inhibitory Concentrations of Phenolic Compounds Derived 
from Herbs and Spices against Bacillus spp. 
                                                        Minimum Inhibitory Concentrations (ppm) 
Compound Solvent pH B. subtilis ATCC 6051 
B. cereus 
Difco S. 
B. polymyxa 
ATCC 842 
Bacillus  
spp. 
Curcumin ETOH 5.54 < 15.0 < 15.0 < 5.0 < 15.0 
Eugenol ETOH  5.54 < 20.0 < 15.0 < 20.0 < 20.0 
Gallic acid H2O 5.14 < 10.0 NA NA < 10.0 
Rosmarinic a. ETOH 5.08 < 15.0 < 10.0 < 15.0 < 15.0 
Thymol ETOH 5.46 < 20.0 < 15.0 < 10.0 < 20.0 
Thymoquinine DMSO 5.59 < 5.0 < 15.0 < 10.0 < 15.0 
Xanthohumol ETOH 8.7 < 5.0 < 20.0 < 5.0 < 20.0 
               NA: not active 
 
 
Table 4.2. Minimum Inhibitory Concentrations of Phenolic Compounds Derived 
from Herbs and Spices against Listeria monocytogenes spp. 
                                                     Minimum Inhibitory Concentrations (ppm) 
Compound Solvent pH LM1 ATCC 7644 
LM2 
UK ADL 
LM3 
ATCC 49594 
LM 
spp. 
Curcumin ETOH 5.54 NA < 20.0 NA < 20.0 
Eugenol ETOH 5.54 < 5.0 < 10.0 < 5.0 < 10.0 
Gallic acid H2O 5.14 NA < 5.0 <10.0 < 10.0 
Rosmarinic a. ETOH 5.08 NA NA NA NA 
Thymol ETOH 5.46 NA NA NA NA 
Thymoquinine DMSO 5.59 < 10.0 < 10.0* < 10.0 < 10.0 
Xanthohumol ETOH 8.7 NA < 5.0 < 5.0 < 5.0 
NA: not active 
*: Incubation period before 24 hours
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Table 4.3. Minimum Inhibitory Concentration of Phenolic Compounds Derived 
from Herbs and Spices against Clostridium spp. 
                                                    Minimum Inhibitory Concentrations (ppm) 
Compound                        pH Solvent C1         RNR 
C2           
ATCC 8260 
C3       
ATCC 7955 
Clostridium 
species 
Curcumin 5.54 ETOH < 5.0 < 5.0 < 5.0 < 5.0 
Eugenol 5.54 ETOH < 20.0 NA NA < 20.0 
Gallic acid 5.14 H2O < 5.0 < 5.0 < 5.0 < 5.0 
Rosmarinic a. 5.08 ETOH NA < 20.0 < 10.0 < 20.0 
Thymol 5.46 ETOH < 5.0 < 5.0 < 5.0 < 5.0 
Thymoquinine 5.59 DMSO < 10.0 NA < 10.0 < 10.0 
Xanthohumol 8.7 ETOH < 5.0 < 5.0 < 5.0 < 5.0 
NA: not active 
 
Table 4.4. Minimum Inhibitory Concentration of Phenolic Compounds Derived 
from Herbs and Spices against Escherichia coli spp. 
                                                     Minimum Inhibitory Concentrations (ppm) 
Compound                        pH Solvent EC1                                   FTJ 
EC2
ATCC 43895 
EC3                      
ATCC 35150 
E. coli 
species 
Curcumin 5.54 ETOH < 20.0 NA < 5.0 < 20.0 
Eugenol 5.54 ETOH < 20.0 < 20.0 < 20.0 < 20.0 
Gallic acid 5.14 H2O < 15.0 < 15.0 < 15.0 < 15.0 
Rosmarinic a. 5.08 ETOH NA NA NA NA 
Thymol 5.46 ETOH < 15.0 < 15.0 < 15.0 < 15.0 
Thymoquinine 5.59 DMSO < 20.0 < 20.0 < 20.0 < 20.0 
Xanthohumol 8.7 ETOH < 15.0 < 15.0 NA < 15.0 
NA: not active 
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Table 4.5. Minimum Inhibitory Concentration of Phenolic Compounds Derived 
from Herbs and Spices against Salmonella spp. 
                                                   Minimum Inhibitory Concentrations (ppm) 
Compound                        pH Solvent S1              UKM 29A 
S2         
ATCC 10708 
S3           
(-) H2S 
Salmonella 
species 
Curcumin 5.54 ETOH < 5.0 < 15.0 < 20.0 < 20.0 
Eugenol 5.54 ETOH < 15.0 < 15.0 < 15.0 < 15.0 
Gallic acid 5.14 H2O < 15.0 NA < 15.0 < 15.0 
Rosmarinic a. 5.08 ETOH < 15.0 < 20.0 < 15.0 < 20.0 
Thymol 5.46 ETOH < 15.0 < 15.0 NA < 15.0 
Thymoquinine 5.59 DMSO < 20.0 < 15.0 < 20.0 < 20.0 
Xanthohumol 8.7 ETOH < 20.0 < 15.0 NA < 20.0 
NA: not active 
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Table 4.6. MICs (ppm) of Phenolic Compounds Derived from Herbs and Spices for Gram-positive bacteria. 
 
 
NA: not active, *: Incubation period before 24 hours 
 
Table 4.7. MICs (ppm) of Phenolic Compounds Derived from Herbs and Spices for Gram-negative bacteria. 
 
 
NA: not active 
 
  
5.54
5.54
5.14
5.08
5.46
5.59
8.7
Gram-positive bacteria
  Compound                       pH B. subtilis           ATCC 6051
B. cereus            
Difco Spores
B. polymyxa        
ATCC 842
LM1            
ATCC 7644
LM2                
UK ADL
LM3              
ATCC 49594
C1                     
RNR
C2           
ATCC 8260
C3           
ATCC 7955
< 5.0
Eugenol < 20.0 < 15.0 < 20.0 < 5.0 < 10.0 < 5.0 < 20.0 NA NA
Curcumin < 15.0 < 15.0 < 5.0 NA < 20.0 NA < 5.0 < 5.0
< 5.0
Rosmarinic a. < 15.0 < 10.0 < 15.0 NA NA NA NA < 20.0 < 10.0
Gallic a. < 10.0 NA NA NA < 5.0 <10.0 < 5.0 < 5.0
< 5.0
Thymoquinine < 5.0 < 15.0 < 10.0 < 10.0 < 10.0* < 10.0 < 10.0 NA < 10.0
Thymol < 20.0 < 15.0 < 10.0 NA NA NA < 5.0 < 5.0
< 5.0Xanthohumol < 5.0 < 20.0 < 5.0 NA < 5.0 < 5.0 < 5.0 < 5.0
5.54
5.54
5.14
5.08
5.46
5.59
8.7
Gram-negative bacteria
  Compound                       pH E. coli                                   FTJ
E. coli 0157:H7             
ATCC 43895
E. coli 0157:H7                    
ATCC 35150
S. paratyphi              
UK Micro 29A
S. cholerasuis subsp.          
ATCC 10708
S. enteridis                             
(-) H2S
Curcumin < 20.0 NA < 5.0 < 5.0 < 15.0 < 20.0
Eugenol < 20.0 < 20.0 < 20.0 < 15.0 < 15.0 < 15.0
Gallic a. < 15.0 < 15.0 < 15.0 < 15.0 NA < 15.0
Rosmarinic a. NA NA NA < 15.0 < 20.0 < 15.0
Thymol < 15.0 < 15.0 < 15.0 < 15.0 < 15.0 NA
Thymoquinine < 20.0 < 20.0 < 20.0 < 20.0 < 15.0 < 20.0
Xanthohumol < 15.0 < 15.0 NA < 20.0 < 15.0 NA
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Table 4.8. MICs (ppm) of Phenolic Compounds Derived from Herbs and Spices for Gram-positive bacteria (after 24 
hours). 
 
 
NA: not active 
 
Table 4.9. MICs (ppm) of Phenolic Compounds Derived from Herbs and Spices for Gram-negative bacteria (after 24 
hours). 
 
 
NA: not active
5.54
5.54
5.14
5.08
5.46
5.59
8.7 < 5.0
NA < 15.0 < 20.0 < 5.0
< 5.0
NA NA < 10.0 < 10.0
NA < 10.0 < 15.0 NA
NA
NA < 5.0 < 10.0 < 15.0
LM3              
ATCC 49594
C1                     
RNR
Xanthohumol < 5.0 < 10.0 < 5.0 < 10.0 < 10.0
NA < 5.0 < 20.0
Thymoquinine < 5.0 < 15.0 < 10.0 NA < 20.0
Thymol < 15.0 < 15.0 < 20.0 NA <15.0
< 10.0 < 5.0 < 5.0
Rosmarinic a. < 5.0 < 20.0 NA NA NA
< 5.0 < 20.0 NA
Gallic a. < 15.0 NA NA NA < 20.0
Eugenol NA < 15.0 < 20.0 < 5.0 < 20.0
C2         
ATCC 8260
C3           
ATCC 7955
Curcumin < 15.0 < 15.0 < 5.0 NA < 20.0
Gram-positive bacteria
  Compound                       pH B. subtilis           ATCC 6051
B. cereus            
Difco Spores
B. polymyxa        
ATCC 842
LM1            
ATCC 7644
LM2                
UK ADL
5.54
5.54
5.14
5.08
5.46
5.59
8.7 NAXanthohumol < 5.0 < 10.0 NA NA < 20.0
NA
Thymoquinine NA NA NA NA < 5.0 < 20.0
Thymol < 20.0 < 15.0 < 15.0 NA NA
< 15.0
Rosmarinic a. NA NA NA NA NA < 15.0
Gallic a. < 10.0 NA < 20.0 NA NA
< 5.0
Eugenol < 20.0 < 20.0 < 20.0 < 20.0 < 20.0 < 15.0
Curcumin < 20.0 NA < 5.0 < 15.0 < 15.0
Gram-negative bacteria
  Compound                       pH E. coli                                   FTJ
E. coli 0157:H7             
ATCC 43895
E. coli 0157:H7                    
ATCC 35150
S. paratyphi              
UK Micro 29A
S. cholerasuis subsp.             
ATCC 10708
S. enteridis                             
(-) H2S
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Figure 4.1. The antimicrobial activity of curcumin at MIC of 15 ppm against B. cereus, 
Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4.2. The antimicrobial activity of curcumin at MIC of 5 ppm against B. polymyxa, 
ATCC 842. Error bars represent standard deviation from the mean, P<0.05.  
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Figure 4.3. The antimicrobial activity of curcumin at MIC of 20 ppm against L. 
monocytogenes, UK ADL. Error bars represent standard deviation from the mean, 
P<0.05. 
 
Figure 4.4. The average antimicrobial activity of curcumin at MIC of 5 ppm against C. 
perfringens, RNR, C. butyricum, ATCC 8260, and C. sporogenes, ATCC 7955. Error 
bars represent standard deviation from the mean, P<0.05. 
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Figure 4.5. The antimicrobial activity ofc at MIC of 20 ppm against E. coli, FTJ. Error 
bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4.6. The antimicrobial activity of curcumin at MIC of 15 ppm against S. 
cholerasuis subsp., ATCC 10708. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 4.7. The antimicrobial activity of eugenol at MIC of 20 ppm against B. subtilis, 
ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4.8. The antimicrobial activity of eugenol at MIC of 15 ppm against B. cereus, 
Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 4.9. The antimicrobial activity of eugenol at MIC of 20 ppm against C. 
perfringens, RNR. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4.10. The average antimicrobial activity of eugenol at MIC of 20 ppm against 
E.coli, FTJ, E. coli O157:H7, ATCC 43895 and E. coli O157:H7, ATCC 35150. Error 
bars represent standard deviation from the mean, P<0.05. 
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Figure 4.11. The antimicrobial activity of eugenol at MIC of 15 ppm against S. 
cholerasuis subsps., ATCC 10708. Error bars represent standard deviation from the 
mean, P<0.05. 
 
 
Figure 4.12. The antimicrobial activity of eugenol at MIC of 15 ppm against S. enteridis, 
(-) H2S. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 4.13. The antimicrobial activity of gallic acid at MIC of 10 ppm against B. 
subtilis, ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
                                                                                                                                 
 
Figure 4.14. The average antimicrobial activity of gallic acid at MIC of 5 ppm against C. 
perfringens, RNR, C. butyricum, ATCC 8260, and C. sporogenes, ATCC 7955. Error 
bars represent standard deviation from the mean, P<0.05. 
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Figure 4.15. The average antimicrobial activity of gallic acid at MIC of 15 ppm against 
E. coli, FTJ, E. coli O157:H7, ATCC 43895, and E. coli O157:H7, ATCC 35150. Error 
bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4.16. The antimicrobial activity of gallic acid at MIC of 15 ppm against S. 
enteridis, (-) H2S. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 4.17. The antimicrobial activity of rosmarinic acid at MIC of 10 ppm against B. 
cereus, Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4.18. The antimicrobial activity of rosmarinic acid at MIC of 20 ppm against C. 
butyricum, ATCC 8260. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 4.19. The antimicrobial activity of rosmarinic acid at MIC of 10 ppm against C. 
sporogenes, ATCC 7955. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4.20. The antimicrobial activity of rosmarinic acid at MIC of 15 ppm against S. 
paratyphi, UK Micro 29A. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 4.21. The antimicrobial activity of rosmarinic acid at MIC of 20 ppm against S. 
cholerasuis subsp., ATCC 10708. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 4.22. The antimicrobial activity of thymol at MIC of 15 ppm against B. cereus, 
Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 4.23. The antimicrobial activity of thymol at MIC of 10 ppm against B. polymyxa, 
ATCC 842. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4.24. The average antimicrobial activity of thymol at MIC of 5 ppm against C. 
perfringens, RNR, C. cholerasuis subsp., ATCC 8260 and C. sporogenes, ATCC 7955. 
Error bars represent standard deviation from the mean, P<0.05. 
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Figure 4.25. The average antimicrobial activity of thymol at MIC of 15 ppm against 
E.coli, FTJ, E. coli O157:H7, ATCC 43985 and E. coli O157:H7, ATCC 35150. Error 
bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4.26. The antimicrobial activity of thymoquinine at MIC of 15 ppm against B. 
cereus, Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 4.27. The antimicrobial activity of thymoquinine at MIC of 10 ppm against C. 
perfringens, RNR. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4.28. The antimicrobial activity of thymoquinine at MIC of 10 ppm against C. 
sporogenes, ATCC 7955. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 4.29. The average antimicrobial activity of thymoquinine at MIC of 5 ppm 
against E. coli, FTJ, E. coli O157:H7, ATCC 438954 and E. coli O157:H7, ATCC 35150. 
Error bars represent standard deviation from the mean, P<0.05. 
 
Figure 4.30. The antimicrobial activity of thymoquinine at MIC of 15 ppm against S. 
cholerasuis subsp., ATCC 10708. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 4.31. The antimicrobial activity of thymoquinine at MIC of 20 ppm against S. 
enteridis, (-) H2S. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4.32. The antimicrobial activity of xanthohumol at MIC of 5 ppm against B. 
subtilis, ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 4.33. The antimicrobial activity of xanthohumol at MIC of 20 ppm against B. 
cereus, Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4.34. The average antimicrobial activity of xanthohumol at MIC of 5 ppm against 
L. monocytogenes, ATCC 7644, L. monocytogenes, UK ADL and L. monocytogenes, 
ATCC 49594. Error bars represent standard deviation from the mean, P<0.05. 
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
0 12 24 36 48 60 
A
bs
or
ba
nc
e 
at
 6
60
 n
m
 
Time (hours) 
Xanthohumol 
Control 
0 
0.05 
0.1 
0.15 
0.2 
0.25 
0.3 
0.35 
0.4 
0.45 
0 12 24 36 48 60 
A
bs
or
ba
nc
e 
at
 6
60
 n
m
 
Time (hours) 
Xanthohumol 
Control 
80 
 
 
Figure 4.35. The average antimicrobial activity of xanthohumol at MIC of 5ppm against 
C. perfringens, RNR, C. butyricum, ATCC 8260 and C. sporogenes, ATCC 7955. Error 
bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4.36. The antimicrobial activity of xanthohumol at MIC of 15 ppm against E. coli, 
FTJ. Error bars represent standard deviation from the mean, P<0.05. 
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CHAPTER 5 
Minimum Inhibitory Concentrations of Natural Antimicrobial Phenolic Compounds 
Extracted from Vegetable and Fruits 
5.1 Introduction 
Results from refereed literature indicate that vegetables and fruits have varying degrees 
of antibacterial activities on common potential pathogens, including antibiotic-resistant 
strains (Lee and others 2003). To address the need for natural and safe alternatives, 
several vegetable and fruit extracts are being used in the food industry, which are natural 
sources of antioxidant and antimicrobial compounds (Perumalla and Hettiarachchy 2011). 
These extracts have the potential to improve the overall quality and extend the shelf life 
of food products. 
The biological properties of extracts (antimicrobial, antioxidant, anticancer, anti-
inflammatory, among other properties) obtained from several parts of vegetables and 
fruits were reported in several previous studies (Kanner and others 1994; Gordon 1996; 
Kris-Etherton and others 2002; Stark and Madar 2002; Miguel and others 2010). Due to 
such properties, the extracts have been used in therapeutics, such as in the prevention of 
infection, inflammation, cancer, among other applications. Recently, there is a search for 
new compounds (Carluccio and others 2003) to study for other applications such as 
preservation and other food safety purposes in food industry as well as novel 
biotechnological techniques (Miguel and others 2010).  
Studies conducted thus far (including human, animal, in vivo and in vitro) have 
demonstrated that olive oil phenolic compounds have positive effects on various 
physiological biomarkers (Owen and others 2000; Waterman and Lockwood 2007), 
implicating phenolic compounds as partially responsible for health benefits associated 
with the Mediterranean diet (Martin-Moreno and others 1994; Visioli and Galli 2002; 
Visioli and Bernardini 2011). Furthermore, olive oil phenolic compounds have been 
shown to be highly bioavailable (Carluccio and others 2003), reinforcing their potential 
health promoting properties (Cicerale and others 2010). 
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The purpose of this study was to determine the antimicrobial activities and the MICs of 
the natural phenolic compounds extracted from vegetables and fruits were evaluated for 
both Gram-positive and Gram-negative foodborne pathogens. Antimicrobial 
Susceptibility Testing Method was conducted to investigate the growth inhibition of 
aerobic foodborne pathogens in Mueller Hinton Broth and anaerobic pathogens in 
Reinforced Clostridial Broth. 
 
5.2 Results and Discussion 
Antimicrobial characteristics of phenolic compounds obtained from fruits and vegetables, 
including caffeic acid, capsaicin, chlorogenic acid, coumarin, decanol, ellagic acid, (-) 
epicatechin, myricetin, naringenin, p-coumaric acid, quercetin, rutin, syringic acid, and 
tannic acid were investigated against foodborne pathogens (NCCLS 2004). In the present 
study tested phenolic compounds were found to be significantly effective against 
inhibiting the growth of both Gram-positive bacteria including Bacillus (Table 5.1), 
Listeria monocytogenes (Table 5.2), Clostridium (Table 5.3), and Gram-negative bacteria 
such as Escherichia coli (Table 5.4) and Salmonella (Table 5.5) species. 
Capsaicin 
Capsaicin showed varying degrees of antimicrobial activity when it was tested against 
various species of foodborne pathogens.  
The three strains of Bacillus; B. subtilis (Figure 5.1), B. cereus (Appendix Figure 27), 
and B. polymyxa (Figure 5.2) showed varying degrees of antimicrobial sensitivity against 
capsaicin. Growth of B. subtilis and B. cereus were inhibited following 60 hours of 
incubation when used at 15 ppm (15 µg/l) and 15 ppm, respectively. However, B. 
polymyxa at 20 ppm concentration showed inhibition until 36 hours of incubation and 
became resistant afterwards. Confirming the findings of this study, (Nazzaro and others 
2009) reported that capsaicin extracted from sweet pepper (Capsicum annuum L.) had 
antibacterial properties for proliferating B. cereus. 
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Capsaicin was observed to have a high antimicrobial activity when it was tested against 
LM2 (Appendix Figure 28) and LM3 (Figure 5.3). MICs of capsaicin against LM2 and 
LM3 were determined to be <20 ppm following 60 hours of incubation period. However, 
LM1 was determined to be highly resistant to capsaicin following 60 hours of incubation 
period. 
The three species of Clostridium; C1, C2, and C3 tested against capsaicin, were 
determined to have very close and consistent sensitivity, with MIC of 5 ppm following 60 
hours of incubation time. Figure 5.4 depicts the average antimicrobial activity of 
capsaicin against the three species of Clostridium tested. 
When Escherichia coli strains were tested with capsaicin, varying degrees of 
antimicrobial activity was observed after 60 hours of incubation. The previous studies 
also reported capsaicin, extracted from sweet pepper (Capsicum annuum L.), being highly 
effective for inhibition of E. coli strains (Nazzaro and others 2009). Confirming these 
results, non-pathogenic E. coli, EC1 (Appendix Figure 29) and E. coli O157:H7, EC2 
(Figure 5.5) were observed to have antimicrobial sensitivity against capsaicin with the 
MIC of 20 ppm. However, EC3 was observed to be highly resistant against capsaicin. 
Salmonella species, S1, S2 and S3 treated with capsaicin showed similar degrees of 
antimicrobial sensitivity following the 60 hours of incubation. The MICs of capsaicin 
against S. paratyphi, S. cholerasuis subsp., and S. enteridis were determined as 20 pmm. 
Figure 5.6 depicts the average antimicrobial activity of capsaicin against those 
Salmonella species.  
Chlorogenic acid 
Chlorogenic acid showed varying degrees of antimicrobial activity when it was tested 
against various strains of foodborne pathogens.  
According to the previous studies, chlorogenic acid extracted from Helichrysum 
(Asteraceae) was reported to have antimicrobial activity against B. subtilis and B. cereus 
(Albayrak and others 2010). In this study, the two strains of Bacillus; B. cereus (Figure 
5.7), and B. polymyxa (Appendix Figure 30) showed similar antimicrobial susceptibility 
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to chlorogenic acid. However, B. subtilis showed no inhibition during the entire 
incubation period. The MICs of B. cereus and B. polymyxa were determined to be 10 
ppm. 
Chlorogenic acid obtained from carrot extracts was reported to be highly antimicrobial 
when tested against L. monocytogenes (Babic and others 1994). Similarly, in this study it 
was observed to have highly consistent antimicrobial activity against three strains of L. 
monocytogenes. MICs of chlorogenic acid against LM1, LM2 and LM3 were determined 
to be 10 ppm following 60 hours of incubation period. Appendix Figure 31 shows the 
average antimicrobial activity of chlorogenic acid throughout the incubation period. 
The two strains of Clostridium; C. butyricum (Figure 5.8), and C. sporogenes (Figure 5.9) 
tested against chlorogenic acid were determined to have similar antimicrobial sensitivity 
when used at <20 ppm. However, C. perfringens was observed to be very resistant 
against chlorogenic acid, showing no antimicrobial susceptibility at all.  
When E. coli species were tested with chlorogenic acid, different degrees of antimicrobial 
activity was observed following 60 hours of incubation. Previous studies reported that 
chlorogenic acid extracted from different type of plants have high antimicrobial activity 
against some strains of E. coli (Babic and others 1994; Albayrak and others 2010; Xia 
and others 2011b). EC1 (Appendix Figure 32) and EC3 (Figure 5.10) were observed to 
have high antimicrobial sensitivity against chlorogenic acid with the MIC of <15 ppm. 
However, EC2 showed very high resistance against chlorogenic acid during the entire 
incubation period, showing no inhibition at all. 
Salmonella species; S. paratyphi, S. cholerasuis subsp., and S. enteridis treated with 
chlorogenic acid showed consistently similar antimicrobial susceptibility following the 
60 hours of incubation. The MICs of chlorogenic acid against S1, S2 and S3 were 
determined as 10 ppm. Figure 5.11 depicts the average antimicrobial activity of 
chlorogenic acid for Salmonella strains at the 60 hours of incubation period. 
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Coumarin 
B. subtilis (Appendix Figure 34), B. cereus (Appendix Figure 35), and B. polymyxa 
(Appendix Figure 36) showed varying degrees of antimicrobial susceptibility when tested 
against coumarin. However, B. polymyxa was observed to gain resistance after 24 hours 
of incubation. The MICs of coumarin for B. subtilis and B. polymyxa were determined as 
20 and 15ppm, respectively. B. cereus showed the highest antimicrobial susceptibility 
against coumarin, with the MIC of 5 ppm following 60 hours of incubation. 
Coumarin showed similar antimicrobial activity against LM1 (Appendix Figure 37), LM2 
(Appendix Figure 38) and LM3 (Appendix Figure 39) but at different incubation stages. 
LM1 and LM2 were sensitive against coumarin with MIC of 5 ppm, consistently being 
inhibited following 60 hours. LM3 was sensitive until 36 hours of incubation with MIC 
of 15 ppm and it gained resistance afterwards.  
The two strains of Clostridium, C. butyricum (Figure 5.12), and C. sporogenes (Figure 
5.13) were observed to have antimicrobial sensitivity when tested against coumarin, 
following 60 hours of incubation. However, C. perfringens showed no antimicrobial 
sensitivity to coumarin, being very resistant during the entire incubation period. MICs of 
coumarin for C. butyricum and C. sporogenes were determined as <10 ppm. 
Previous studies reported coumarin being highly antimicrobial especially for Gram-
negative bacteria including E. coli and Salmonella species (Maddox and others 2010). 
Confirming those reports, coumarin was observed to inhibit the growth of EC1 
(Appendix Figure 40) following 60 hours of incubation period, with the MIC of 20 ppm. 
It was observed not to be effective when used at decreasing concentrations. However, 
after being treated with coumarin neither EC2 nor EC3 observed to be sensitive during 
the entire 60 hours of incubation period. 
S. paratyphi (Appendix Figure 41), S. cholerasuis subsp. (Appendix Figure 42) and S. 
enteridis (Figure 5.14) were observed to be consistently sensitive against coumarin 
following 60 hours of incubation. The MICs of coumarin were determined as <15 ppm 
for all of those strains.  
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Decanol 
All of the Bacillus strains were observed to be sensitive at varying degrees against 
decanol. B. subtilis (Figure 5.15), B. cereus (Figure 5.16) and B. polymyxa (Figure 5.17) 
showed high antimicrobial susceptibility with MIC of <10 ppm, after 60, 24 and 24 hours 
of incubation, respectively. B. cereus and B. polymyxa were observed to gain resistance 
after 24 hours incubation. 
Decanol was observed to be very effective against inhibiting the growth of LM2 (Figure 
5.18) and LM3 (Appendix Figure 43) following 60 hours of incubation, with 20 ppm 
concentrations. However, LM1 showed very high resistance against decanol during the 
entire incubation period. Most of the results were confirmed by the previous studies done 
by (Elgaali and Newman 2005), where decanol was also found to have antimicrobial 
activity for several strains of L. monocytogenes. 
When treated with decanol two strains of Clostridium were observed to have similar 
antimicrobial susceptibility at different incubation stages. MICs of decanol for C. 
perfringens (Appendix Figure 44) and C. butyricum (Figure 5.19) were determined to be 
5 ppm after 36 and 60 hours of incubation period, respectively. C. perfringens showed 
resistance after 36 hours of incubation while C. sporogenes was observed to be highly 
resistant against decanol during the entire incubation period of 60 hours.  
Decanol was observed to have consistently high antimicrobial activity against EC1 
(Figure 5.20), EC2 and EC3 (Figure 5.21) when used at <10 ppm concentrations, 
following 60 hours of incubation.  
Salmonella species tested against decanol were observed to have varying degrees of 
antimicrobial susceptibility. S. paratyphi (Figure 45), S. cholerasuis subsp. (Figure 46) 
and S. enteridis (Figure 5.22) were determined to be sensitive to decanol during the entire 
incubation period, when used at <15 ppm concentrations.  
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Ellagic Acid 
Ellagic acid was previously reported to have a high potential for being a promising 
antimicrobial compound against both Gram-positive and Gram-negative pathogens, 
including oral pathogens in human (Loo and others 2010; Miguel and others 2010).  
The three strains of Bacillus; B. subtilis (Figure 5.23), B. cereus (Figure 5.24) and B. 
polymyxa (Appendix Figure 47) showed similar antimicrobial susceptibility to ellagic 
acid, at <10 ppm concentrations. Growth of B. cereus was inhibited at 24 hours of 
incubation and it gained resistance afterwards through the 60 hours of incubation period, 
while B. polymyxa showed resistance after 12 hours of incubation.  
Ellagic acid was observed to have highly consistent antimicrobial activity when it was 
tested against LM1, LM2, and LM3.  MICs of ellagic acid were determined to be 5 ppm 
following 60 hours of incubation period for all of the strains. Figure 5.25 shows the 
average antimicrobial activity of ellagic acid throughout the entire incubation period 
when tested against L. monocytogenes strains. 
The two strains of Clostridium; C. perfringens (Appendix Figure 48) and C. butyricum 
(Appendix Figure 49) were observed to be highly sensitive against ellagic acid, when 
used at <5 ppm concentrations at 60 hours of incubation. However, C. perfringens 
showed antimicrobial resistance after 36 hours of incubation. When C. sporogenes 
treated with ellagic acid, it was determined to be highly resistant throughout the entire 60 
hours of incubation period. 
When ellagic acid was tested against E. coli strains of EC1, EC2, and EC3, two of them; 
EC1 (Figure 5.26) and EC2 (Figure 5.27) showed high growth inhibition after 60 hours of 
incubation. However, EC3 was observed to be highly resistant against ellagic acid, 
showing no inhibition at any stage of the 60 hour incubation period. The MICs of ellagic 
acid were determined to be 20 ppm for both EC1 and EC2, following 60 hours. These 
results confirm the previous research findings where, ellagic acid extracted from 
pomegranate was found to be highly effective against inhibiting several strains of E. coli 
(Duman and others 2009). 
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Salmonella species, S. paratyphi (Appendix Figure 50), S. cholerasuis subsp. (Figure 
5.28), and S. enteridis (Appendix Figure 51) treated with ellagic acid showed varying 
degrees of antimicrobial susceptibility following the 60 hours of incubation. The MICs of 
ellagic acid tested against S. paratyphi, S. cholerasuis subsp. and S.enteridis were 
determined as 20, 10, and 15 ppm, respectively. 
(-) Epicatechin 
Both Gram-positive and Gram-negative pathogens have been previously reported to have 
antimicrobial susceptibility when tested against (-) epicatechin (Theivendran and others 
2006; Askun and others 2009a). 
When treated with (-) epicatechin, B. subtilis (Appendix Figure 52), B. cereus (Appendix 
Figure 53) and B. polymyxa (Figure 5.29), were observed to have antimicrobial 
susceptibility when used at 20 ppm concentrations and incubated for 60 hours. These 
results confirm the previous findings of Askun and others (2009a) where they observed 
that Bacillus species were susceptible when treated with several different levels of  (-) 
epicatechin.  
According to Theivendran and others (2006) when (-) epicatechin derived from green tea 
used on edible film coating, it was observed to be promising as means of controlling the 
growth and recontamination of L. monocytogenes on ready-to-eat meat products. (-) 
Epicatechin showed close antimicrobial activity for LM2 (Appendix Figure 54) and LM3 
(Appendix Figure 55), but at different incubation stages. (-) Epicatechin was effective at 
inhibiting the growth of both strains with the MIC of 5 ppm. LM2 gained resistance after 
36 hours, showing no inhibition afterwards, while LM3 was observed to be resistant after 
12 hours of incubation. LM1 was observed to be highly resistant to (-) epicatechin during 
the entire incubation period. 
The two strains of Clostridium; C. perfringens (Appendix Figure 56) and C.butyricum 
(Figure 5.30) were observed to have similar antimicrobial sensitivity when tested against 
20 ppm (-) epicatechin following 60 hours of incubation. C. perfringens showed initial 
antimicrobial susceptibility after 24 hours of incubation. C. sporogenes (Figure 5.31) was 
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determined to have higher antimicrobial sensitivity against (-) epicatechin, when used at 
10 ppm concentration following 60 hours of incubation. 
(-) Epicatechin was observed to inhibit the growth of EC1 (Figure 5.32), EC2 (Appendix 
Figure 57) and EC3 (Appendix Figure 58) when used at <20 ppm concentrations. EC2 
gained resistance after 12 hours of incubation, showing no antimicrobial susceptibility 
afterwards. EC1 and EC3 were observed to be consistently susceptible following 60 and 
24 hours of incubation time, respectively. The results of this study confirm the findings of 
previous studies, where E. coli species were reported to be inhibited when treated with (-) 
epicatechin (Taguri and others 2004; Bancirova 2010; Cueva and others 2010) and the 
susceptibility of E. coli being strain dependent (Cueva and others 2010).  
In previous studies Salmonella species were reported to be highly susceptible to (-) 
epicatechin (Taguri and others 2004). Confirming those results, S. paratyphi, S. 
cholerasuis subsp., and S. enteridis were observed to be consistently sensitive against (-) 
epicatechin after being incubated for 60 hours. The MIC of (-) epicatechin was 
determined as 15 ppm for all of those Salmonella species and Figure 5.33 shows their 
average antimicrobial susceptibility against (-) epicatechin.  
Myricetin  
Myricetin was reported being very effective against inhibiting some species of both 
Gram-positive and Gram-negative pathogenic bacteria (Tsai and others 2008; Freeman 
and others 2010). 
The two species of Bacillus; B subtilis (Appendix Figure 59), and B. cereus (Figure 5.34) 
showed consistently close antimicrobial susceptibility to myricetin. However, B. 
poylymxa showed high resistance during the entire incubation period. The MICs of B. 
subtilis, and B. cereus were determined to be 15 ppm, after 48 and 60 hours of incubation 
period, respectively. 
Listeria strains; LM1, LM2 and LM3 treated with myricetin were observed to have 
highly consistent antimicrobial resistance throughout the entire 60 hours of incubation 
period. Contrarily, according to Yao and others (2011) myricetin extracted from Chinese 
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bayberry fruit (Myrica rubra) has antimicrobial activity against some strains of L. 
monocytogenes. 
C. butyricum (Figure 5.35), and C. sporogenes (Figure 5.36) tested against myricetin 
were determined to have very similar antimicrobial sensitivity when used at low 
concentrations (<10 ppm) following 60 hours of incubation. However, C. perfringens 
was observed to be very resistant against myricetin, showing no antimicrobial 
susceptibility at all.  
When E. coli species were treated with myricetin, different degrees of antimicrobial 
activity were observed following 60 hours of incubation. Most of the results were 
consistent with previous studies of myricetin tested against E. coli species (Yao and 
others 2011). EC1 (Figure 5.37), EC2 (Appendix Figure 60) and EC3 (Appendix Figure 
61) were observed to have similar antimicrobial sensitivity against myricetin with the 
MIC of <20 ppm. However, EC2 gained resistance after 36 hours of incubation and 
showed no sensitivity afterwards.  
S. paratyphi (Appendix Figure 62) was observed to have antimicrobial susceptibility 
against myricetin, when used at 20 ppm concentration at 36 hours of incubation. 
However, it gained resistance afterwards and showed no inhibition until the end of 
incubation time. S. cholerasuis subsp. (Figure 5.38) and S. enteridis (Appendix Figure 
63) were also found to be susceptible when treated with lower concentrations (<15 ppm), 
following 60 hours of incubation. The MICs of myricetin against S. paratyphi, S. 
cholerasuis subsp., and S. enteridis were determined as 20, 15, and 5 ppm, respectively. 
Similarly, Yao and others (2011) also reported myricetin having high in vitro 
antimicrobial activity for S. paratyphi and S. enteridis. 
Quercetin 
Quercetin extracted from various plants including, onions, navel oranges and berries was 
previously studied against pathogenic bacteria, including Gram-positive, Gram-negative, 
cariogenic and periodontal pathogens. It was found to be highly effective against most of 
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the strains tested in vitro (Tsai et al. 2008; Freeman et al. 2010; Geoghegan et al. 2010; 
Santas and others 2010; Yao et al. 2011). 
When tested against quercetin, B. cereus (Appendix Figure 65), and B. polymyxa (Figure 
5.39) were observed to have similar antimicrobial susceptibility when exposed to <20 
ppm concentrations. B. subtilis (Appendix Figure 64) also showed inhibition at 36 hours 
when treated with 15 ppm of quercetin and gained resistance afterwards. B. cereus and B. 
polymyxa were consistently susceptible throughout the entire 60 hours of incubation. 
Similarly, both B. subtilis and B. cereus (Askun and others 2009b; Santas and others 
2010) were previously found to be susceptible when treated with quercetin (Pereira and 
others 2007b). 
Listeria monocytogenes strains; LM1, LM2 and LM3 tested with quercetin showed 
highly consistent antimicrobial resistance, after being incubated for 60 hours. Contrarily, 
in the previous studies (Santas and others 2010; Yao and others 2011) quercetin was 
stated being effective against inhibiting the growth of several strains of L. 
monocytogenes. 
C. perfringens was observed to have no inhibition when treated with quercetin at 60 
hours of incubation period. However, C. butyricum (Figure 5.40) and C. sporogenes 
(Figure 5.41) were found to have high antimicrobial sensitivity against quercetin 
following 60 hours of incubation period. MICs of quercetin for both species were 
determined to be 15 ppm.  
Quercetin was observed to have highly consistent antimicrobial activity when it was 
tested against EC1, EC2, and EC3.  MICs of quercetin were determined to be 5 ppm after 
24, 60 and 24 hours of incubation period, respectively. The findings of this study confirm 
the previous studies regarding quercetin, where it was also found to have high 
antimicrobial activity for E. coli strains (Askun and others 2009a; Santas and others 
2010; Yao and others 2011). However, according to Pereira and others (2007b) E. coli 
showed antimicrobial resistance against quercetin, which was extracted from walnuts. 
Figure 5.42 exhibits the average antimicrobial activity of EC1, EC2, and EC3. 
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According to Yao and others (2011) S. paratyphi and S. enteridis showed high 
antimicrobial susceptibility in vitro when treated with quercetin. In this study, S. 
paratyphi (Appendix Figure 66), S. cholerasuis subsp. (Figure 5.43) and S. enteridis 
(Appendix Figure 67) were observed to be consistently sensitive against quercetin after 
being incubated for 60 hours. The MICs of quercetin were determined as <20 ppm for all 
of those strains.  
Rutin 
Rutin was previously reported as having high antimicrobial activity for Gram-positive 
and mostly for fastidious Gram-negative pathogenic bacteria (Pereira and others 2007a; 
Askun and others 2009b; Maddox and others 2010). Especially, E. coli and Bacilli 
species were found to be the most susceptible pathogens (Pereira, Ferreira and others 
2007; Askun, Tumen and others 2009). 
B. subtilis (Figure 5.43), B. cereus (Figure 5.44), and B. polymyxa (Figure 5.45) showed 
varying degrees of antimicrobial susceptibility when tested against rutin. The MICs of 
rutin for B. subtilis, B. cereus and B. polymyxa were determined as <15 ppm. Rutin 
showed a consistent antimicrobial activity for B. subtilis and B. cereus following 60 
hours of incubation. However, B. polymyxa was observed to be susceptible after 36 hours 
of incubation. Lee and Lee (2010) previously reported that rutin extracted from olives 
does not have any antimicrobial affect against B. cereus. However, according to Singh 
and others (2008) rutin, extracted from Brake Fern (Pteris vittata) exhibited potent 
activity for B. cereus with the MIC value of 0.03 mg/ml. B. subtilis was also previously 
found to show antimicrobial susceptibility when tested with rutin in vitro (Pereira and 
others 2007a; Askun and others 2009b). 
Rutin showed similar antimicrobial activity against Listeria monocytogenes strains tested 
at 60 hours of incubation period. LM1 (Figure 5.46), LM2 (Figure 5.47) and LM3 
(Appendix Figure 68) were observed to be sensitive against rutin, with MIC of <15 ppm, 
following 60 hours.  
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The two strains of Clostridium; C. butyricum, and C. sporogenes were observed to have 
high antimicrobial resistance when tested against rutin, at 60 hours of incubation period. 
However, C. perfringens (Appendix Figure 69) showed antimicrobial susceptibility to 
rutin. MIC of rutin for C. perfringens was determined as 10 ppm following 60 hours of 
incubation. 
Rutin was observed to inhibit the growth of tested E. coli strains showing varying degrees 
of antimicrobial activity. EC1 (Appendix Figure 70), EC2 (Appendix Figure 71) and EC3 
(Appendix Figure 72) were observed to be sensitive when incubated for 60 hours. MICs 
of rutin against EC1, EC2 and EC3 were determined as <20 ppm. Confirming the 
findings of this study, previous studies also reported E .coli O157:H7 and other E. coli 
strains being highly susceptible to rutin in vitro (Pereira and others 2007a; Askun and 
others 2009b). However, according to Lee and Lee (2010) some E. coli strains were not 
inhibited when treated and incubated with rutin in vitro. 
Previous studies reported that rutin was highly effective against inhibiting the growth of 
some Salmonella species in vitro (Askun and others 2009a). S. cholerasuis subsp. 
(Appendix Figure 74) and S. enteridis (Appendix Figure 75) were observed to be 
consistently sensitive against rutin following 60 hours of incubation. The MICs of rutin 
were determined as 15 ppm for both of those species. Moreover, rutin also showed 
antimicrobial activity against S. paratyphi (Appendix Figure 73) but when used at 20 
ppm concentration following 60 hours of incubation (MIC of 20 ppm). However, Lee and 
Lee (2010) previously reported S. enteridis being not susceptible to rutin, which was 
extracted from olives. 
Tannic Acid 
When tested against tannic acid, only B. subtilis (Appendix Figure 76) was observed to 
have antimicrobial susceptibility until the incubation period of 36 hours. Afterwards it 
gained resistance and showed no susceptibility. B. polymyxa and B. cereus were found to 
be highly resistant to tannic acid even when used at higher concentrations. MIC of B. 
subtilis was determined as 20 ppm after being incubated for 36 hours. 
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Tannic acid showed varying degrees of antimicrobial activity against LM1 (Appendix 
Figure 77) and LM2 (Appendix Figure 78) and LM3 (Appendix Figure 79) when used at 
different concentrations. LM1 was observed to be the most sensitive when used at 
concentration as low as 10 ppm. LM2 gained resistance after 36 hours when treated with 
15 ppm concentration of tannic acid, while LM1 and LM3 were consistently sensitive 
throughout the entire incubation period. MICs of tannic acid for LM1, LM2, and LM3 
were determined to be 10, 15 and 20 ppm, respectively. 
C. perfringens (Figure 5.48), C. butyricum (Figure 5.49) and C. sporogenes (Appendix 
Figure 80) were observed to have varying degrees of antimicrobial sensitivity when 
tested against tannic acid at 60 hours of incubation. MIC of tannic acid for C. 
perfringens, C. butyricum and C. sporogenes were determined to be <20 ppm. 
Previous studies regarding tannic acid showed that several strains of E. coli were 
observed to have high antimicrobial susceptibility for tannic acid (Taguri and others 
2004; Bancirova 2010). The present study confirms the previous findings, where tannic 
acid was observed to inhibit the growth of EC1 (Appendix Figure 81) and E3 (Figure 
5.50) when used at 5 ppm and 20 ppm concentrations, respectively. However EC2 was 
observed to be highly resistant against tannic acid during the entire incubation period. 
MICs of tannic acid were determined as 5 and 20 against EC1 and EC3, respectively. 
Tannic acid was observed to have high antimicrobial activity against S. paratyphi 
(Appendix Figure 82), and S. cholerasuis subsp. (Appendix Figure 83) and S. enteridis 
(Appendix Figure 84) when used at 15, 10 and 15 ppm concentrations, respectively. The 
previous studies regarding tannic acid (Taguri and others 2004) confirmed the findings of 
the present study, where Salmonella species were also found to have antimicrobial 
susceptibility. 
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5.3 Phenolic Compounds having Antimicrobial Activity only against Bacillus spp. 
Some of the natural phenolic compounds did not exhibit any antimicrobial activity for 
any kind of pathogens but Bacillus spp. Caffeic acid, naringenin, p-coumaric acid and 
syringic acid (Kosina and others 2010) were previously reported to have antimicrobial 
activity towards Gram-positive, Listeria innocua (Mandalari and others 2007), Bacillus 
spp. (Mandalari and others 2007; Askun and others 2009a), Salmonella spp. (Mandalari 
and others 2007; Tsai and others 2008; Askun and others2009a) and Gram-negative 
bacteria including E. coli (Mandalari and others 2007; Askun and others 2009a), 
Salmonella spp.,  and E. aerogenes (Askun and others 2009b). The results of this study 
confirm these studies having similar antimicrobial activities (Table 5.6). 
Caffeic acid was observed to have antimicrobial activity on B. subtilis following the 24 
hour incubation period, when used at 15 ppm concentrations. According to Askun and 
others (2009a) B. cereus was reported being sensitive to caffeic acid between the MIC 
range of 1280-10240 µg/ml. However, in this study the results revealed B. cereus being 
highly resistant to caffeic acid. Naringenin was determined to have high antimicrobial 
effects against B. subtilis, B. cereus, B. polymyxa with the MICs of <10 ppm following 
60, 12 and 12 hours of incubation time. 
B. subtilis and B. polymyxa were observed to have high antimicrobial susceptibility 
against syringic acid, with the MICs of 5 ppm following 60 and 12 hours of incubation 
time, respectively. Previous studies show that syringic acid, extracted from olive leaves 
was highly resistant against B. cereus (Korukluoglu and others 2010), however Yang and 
others (2010) reported B. subtilis being highly susceptible when treated with syringic acid 
extracted from Canthium horridum stems. 
When treated with p-coumaric acid, B. subtilis and B. cereus were found to be highly 
susceptible, with MICs of 5 ppm following 36 and 12 hours of incubation time. 
Confirming these results Acar and others (2010) reported that p-coumaric acid extracted 
from Crocus baytopiorum has high antimicrobial activity against both B. subtilis and B. 
cereus. 
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5.4 Conclusion 
The results revealed that different bacterial species exhibit varying antimicrobial 
sensitivities towards the tested phenolic compounds. Generally, the Gram-negative 
bacteria (E. coli and Salmonella) were observed to have more antimicrobial susceptibility 
than Gram-positives (Bacilli, Listeria, and Clostridium) following 60 hours of incubation.  
In addition, different strains of the same bacterial species showed differences in 
antimicrobial sensitivity, with varying concentrations of phenolic compounds. Therefore, 
each phenolic compound had different MIC for each bacterial strain. Figure 5.7 and 
Figure 5.8 depict the summary of MICs of both Gram-positive and Gram-negative 
pathogens, respectively. However, chlorogenic acid and ellagic acid had the same MICs 
(<10 ppm) for all strains of Listeria monocytogenes, where capsaicin had MIC of 5 ppm 
for all species of Clostridium and MIC of 20 ppm for Salmonella species. Moreover, all 
three strains of E. coli showed consistent antimicrobial susceptibility against quercetin, 
with the MICs of 5 ppm, where chlorogenic acid had MICs of 20 ppm for all strains of 
Salmonella. (-) Epicatechin was also consistently effective inhibiting the growth of all 
Salmonella species (MIC 15 ppm) and Bacillus species (MIC 20 ppm). Interestingly, 
quercetin and myricetin obtained from berries were determined to have no antibacterial 
activity for Listeria monocytogenes species. 
Overall, ellagic acid, (-) epicatechin, capsaicin and rutin determined to be the most 
effective natural phenolic compounds against both Gram-positive and Gram-negative 
pathogens. The investigated strength of antimicrobial activity was followed by decanol, 
tannic acid, coumarin, chlorogenic acid, quercetin and myricetin, respectively. Each 
vegetable exhibits peculiar biochemical and nutritional characteristics, influenced by the 
species of belonging and, within the same species, by the variety, stage of ripening and 
technique of breeding (Andarwulan and Shetty 1999). Thus, the entire interaction among 
different factors becomes essential, influencing the content and composition of 
antibacterial and antioxidant biomolecules (Nazzaro and others 2009).  
For the first time in literature, current study reported the antimicrobial activity of 
phenolics through 60 hours of incubation. The MICs were determined for both 24 hours 
97 
 
and 60 hours of incubation where the change in growth characteristics of foodborne 
pathogens was revealed. These findings provide evidence for the impact of natural 
phenolic compounds in food safety where the food is exposed to long term storage. Table 
5.9 and Table 5.10 depict the MICs of phenolics for both Gram-positive and Gram-
negative pathogens after 24 hours of incubation. 
The results of this study suggest that the sensitivity of the pathogenic bacteria to natural 
phenolic compounds depends on bacterial species, source and polyphenol structure of the 
phenolics. Incubation period is another factor affecting the bacterial growth, where some 
of the sensitive pathogens may recover and become resistant after 24 hours of incubation. 
The usage of plant based antimicrobials can be alternatives for chemicals used in food 
preservation. In fact, phenolic and non-phenolic compounds in the plant extracts have the 
potential inhibitory activity against pathogenic bacteria (Cowan 1999). Furthermore, the 
genetic diversity, agronomical practices, and environmental conditions, the composition 
of critical compounds in herb and plant extracts exhibit differences in their efficacy 
against foodborne pathogens (Theivendran and others 2006).  
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Table 5.1. Minimum Inhibitory Concentration of Phenolic Compounds Derived 
from Vegetables and Fruits against Bacillus spp. 
                                                     Minimum Inhibitory Concentrations (ppm) 
Compound pH Solvent B. subtilis ATCC 6051 
B. cereus 
Difco S. 
B. polymyxa 
ATCC 842 
Bacillus 
species 
Capsaicin 5.4 ETOH < 15.0 < 20.0 < 20.0 < 20.0 
Chlorogenic a. 5.62 ETOH NA < 10.0 < 10.0* < 10.0 
Coumarin 6.1 ETOH < 20.0 < 5.0 < 15.0 < 20.0 
Decanol 4.77 Prop. g. < 5.0 < 10.0* < 5.0* < 10.0 
Ellagic a. 5.44 Prop. g. < 10.0 < 10.0 < 5.0* < 10.0 
(-) Epicatechin 5.6 ETOH < 20.0 < 20.0 < 20.0 < 20.0 
Myricetin 6.46 ETOH < 15.0 < 15.0 NA < 15.0 
Quercetin 7.18 ETOH < 15.0 < 20.0 < 10.0 < 20.0 
Rutin 5.65 ETOH < 15.0 < 5.0 < 10.0 < 15.0 
Tannic a. 5.4 ETOH < 20.0 NA NA < 20.0 
NA: Not active 
*: Incubation period before 24 hours 
 
 
Table 5.2. Minimum Inhibitory Concentration of Phenolic Compounds Derived 
from Vegetables and Fruits against Listeria monocytogenes spp. 
                                                      Minimum Inhibitory Concentrations (ppm) 
Compound                        pH Solvent LM1  ATCC 7644 
LM2        
UK ADL 
LM3  
ATCC 49594 
LM 
 spp. 
Capsaicin 5.4 ETOH NA < 20.0 < 10.0 < 20.0 
Chlorogenic a. 5.62 ETOH < 10.0 < 10.0 < 10.0 < 10.0 
Coumarin 6.1 ETOH < 5.0* < 5.0 < 15.0 < 15.0 
Decanol 4.77 Prop. g. NA < 20.0 < 20.0 < 20.0 
Ellagic a. 5.44 Prop. g. < 5.0 < 5.0 < 5.0 < 5.0 
(-) Epicatechin 5.6 ETOH NA < 5.0 < 5.0* < 5.0 
Myricetin 6.46 ETOH NA NA NA NA 
Quercetin 7.18 ETOH NA NA NA NA 
Rutin 5.65 ETOH < 5.0 < 10.0 < 15.0 < 15.0 
Tannic a. 5.4 ETOH < 10.0 < 15.0 < 20.0 < 20.0 
NA: Not active 
*: Incubation period before 24 hours 
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Table 5.3. Minimum Inhibitory Concentration of Phenolic Compounds Derived 
from Vegetables and Fruits against Clostridium spp. 
                                                        Minimum Inhibitory Concentrations (ppm)  
Compound                        pH Solvent C1                      RNR 
C2          
ATCC 8260 
C3           
ATCC 7955 
Clostridium 
species 
Capsaicin 5.4 ETOH < 5.0 < 5.0 < 5.0 < 5.0 
Chlorogenic a. 5.62 ETOH NA < 20.0 < 5.0 < 20.0 
Coumarin 6.1 ETOH NA < 10.0 < 5.0 < 10.0 
Decanol 4.77 Prop. g. < 5.0 < 5.0 NA < 5.0 
Ellagic a. 5.44 Prop. g. < 5.0 < 15.0 NA < 15.0 
(-) Epicatechin 5.6 ETOH < 20.0 < 20.0 < 10.0 < 20.0 
Myricetin 6.46 ETOH NA < 5.0 < 10.0 < 10.0 
Quercetin 7.18 ETOH NA < 15.0 < 15.0 < 15.0 
Rutin 5.65 ETOH < 10.0 NA NA < 10.0 
Tannic a. 5.4 ETOH < 20.0 < 20.0 < 10.0 < 20.0 
NA: Not active 
 
Table 5.4. Minimum Inhibitory Concentration of Phenolic Compounds Derived 
from Vegetables and Fruits against E.coli spp. 
                                                    Minimum Inhibitory Concentrations (ppm) 
Compound pH Solvent EC1                                   FTJ 
EC2
ATCC 43895 
EC3                    
ATCC 35150 
E. coli 
species 
Capsaicin 5.4 ETOH < 20.0 < 20.0 NA < 20.0 
Chlorogenic a. 5.62 ETOH < 15.0 NA < 10.0 < 15.0 
Coumarin 6.1 ETOH < 20.0 NA NA < 20.0 
Decanol 4.77 Prop. g. < 10.0 < 5.0 < 5.0 < 10.0 
Ellagic a. 5.44 Prop. g. < 20.0 < 20.0 NA < 20.0 
(-) Epicatechin 5.6 ETOH < 20.0 < 5.0* < 10.0 < 20.0 
Myricetin 6.46 ETOH < 20.0 < 10.0 < 15.0 < 20.0 
Quercetin 7.18 ETOH < 5.0 < 5.0 < 5.0 < 5.0 
Rutin 5.65 ETOH < 20.0 < 5.0 < 15.0 < 20.0 
Tannic a. 5.4 ETOH < 5.0 NA < 20.0 < 20.0 
NA: Not active 
*: Incubation period before 24 hours 
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Table 5.5. Minimum Inhibitory Concentration of Phenolic Compounds Derived 
from Vegetables and Fruits against Salmonella spp. 
                                                         Minimum Inhibitory Concentrations (ppm) 
Compound pH Solvent S1              UKM 29A 
S2        
ATCC 10708 
S3                             
(-) H2S 
Salmonella 
species 
Capsaicin 5.4 ETOH < 20.0 < 20.0 < 20.0 < 20.0 
Chlorogenic a. 5.62 ETOH < 10.0 < 10.0 < 10.0 < 10.0 
Coumarin 6.1 ETOH < 15.0 < 15.0 < 5.0 < 15.0 
Decanol 4.77 Prop. g. < 15.0 < 15.0* < 10.0 < 15.0 
Ellagic a. 5.44 Prop. g. < 20.0 < 10.0 < 15.0 < 20.0 
(-) Epicatechin 5.6 ETOH < 15.0 < 15.0 < 15.0 < 15.0 
Myricetin 6.46 ETOH < 20.0 < 15.0 < 5.0 < 20.0 
Quercetin 7.18 ETOH < 20.0 < 15.0 < 10.0 < 20.0 
Rutin 
 
5.65 ETOH < 20.0 < 15.0 < 15.0 < 20.0 
Tannic a. 5.4 ETOH < 15.0 < 10.0 < 15.0 < 15.0 
NA: Not active 
*: Incubation period before 24 hours 
 
 
Table 5.6. Minimum Inhibitory Concentration of Phenolic Compounds Derived 
from Vegetables and Fruits against Bacillus spp. (2) 
                                                   Minimum Inhibitory Concentrations (ppm)  
Compound                        pH Solvent B. subtilis ATCC 6051 
B. cereus 
Difco S. 
B. polymyxa 
ATCC 842 
Bacillus  
spp. 
Caffeic a. 6.1 H2O < 15.0 NA NA < 15.0 
Naringenin 6.04 ETOH < 5.0 < 5.0* NA < 5.0 
p-Coumaric a. 6.15 H2O < 5.0 < 5.0* NA < 5.0 
Syringic a. 6.08 ETOH < 5.0 NA < 5.0* < 5.0 
NA: Not active 
*: Incubation period before 24 hours 
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Table 5.7. MICs (ppm) of Phenolic Compounds Derived from Vegetables and Fruits for Gram-positive bacteria. 
 
NA: Not active, *: Incubation period before 24 hours 
 
Table 5.8. MICs (ppm) of Phenolic Compounds Derived from Vegetables and Fruits for Gram-negative bacteria. 
 
NA: Not active, *: Incubation period before 24 hour 
 
5.4
5.62
6.1
4.77
5.44
5.6
6.46
7.18
5.65
5.4
Gram-positive bacteria
         
Compound                       pH
B. subtilis           
ATCC 6051
B. cereus         
Difco Spores
B. polymyxa   
ATCC 842
LM1            
ATCC 7644
LM2                
UK ADL
LM3              
ATCC 49594
C1                     
RNR
C2             
ATCC 8260
C3           
ATCC 7955
NA < 10.0 < 10.0 < 10.0 < 10.0 < 10.0 NA < 20.0 < 5.0
< 5.0
Decanol < 5.0 < 10.0* < 5.0* NA < 20.0 < 20.0 < 5.0 < 5.0 NA
Coumarin < 20.0 < 5.0 < 15.0 < 5.0* < 5.0 < 15.0 NA < 10.0
< 10.0 < 10.0 < 5.0* < 5.0 < 5.0 < 5.0 < 5.0 < 15.0 NA
< 20.0 < 20.0 < 10.0
Myricetin < 15.0 < 15.0 NA NA NA NA
< 20.0 < 20.0 < 20.0 NA < 5.0 < 5.0*
NA < 5.0 < 10.0
NA NA NA < 15.0 < 15.0
Rutin < 15.0 < 5.0 < 10.0 < 5.0 < 10.0 < 15.0 < 10.0 NA
< 20.0 NA NA < 10.0 < 15.0 < 20.0 < 20.0 < 20.0 < 10.0
< 5.0Capsaicin < 15.0 < 20.0 < 20.0 NA < 20.0 < 10.0 < 5.0 < 5.0
NA
Quercetin < 15.0 < 20.0
Tannic a.
(-) Epicatechin
Ellagic a.
Chlorogenic a.
< 10.0 NA
5.4
5.62
6.1
4.77
5.44
5.6
6.46
7.18
5.65
5.4
< 15.0 < 15.0* < 10.0
< 20.0 NA NA < 15.0 < 15.0 < 5.0
< 10.0 < 5.0 < 5.0
< 15.0 <15.0 < 15.0
< 20.0 < 20.0 NA < 20.0 < 10.0 < 15.0
< 20.0 < 5.0* < 10.0
< 20.0 < 15.0 < 15.0
< 20.0 < 10.0 < 15.0 < 20.0 < 15.0 < 5.0
< 20.0 < 5.0 < 15.0
< 15.0 < 10.0 < 15.0
< 5.0 < 5.0 < 5.0 < 20.0 < 15.0 < 10.0
< 5.0 NA < 20.0
< 10.0 < 10.0 < 10.0
Gram-negative bacteria
E. coli                                   
FTJ
E. coli 0157:H7                
ATCC 43895
E. coli 0157:H7                    
ATCC 35150
S. paratyphi              
UK Micro 29A
S. cholerasuis subsp. 
ATCC 10708
S. enteridis                             
(-) H2S
< 20.0 < 20.0 < 20.0Capsaicin < 20.0 < 20.0 NA
  Compound                       pH
< 15.0 NA < 10.0
Tannic a.
(-) Epicatechin
Ellagic a.
Chlorogenic a.
Quercetin
Coumarin
Decanol
Myricetin
Rutin
101 
102 
 
 
 
Table 5.9. MICs (ppm) of Phenolic Compounds Derived from Vegetables and Fruits for Gram-positive bacteria (after 
24 hours). 
 
NA: Not active 
 
Table 5.10. MICs (ppm) of Phenolic Compounds Derived from Vegetables and Fruits for Gram-negative bacteria (after 
24 hours). 
 
NA: Not active 
5.4
5.62
6.1
4.77
5.44
5.6
6.46
7.18
5.65
5.4
< 10.0 < 10.0NA < 20.0 < 20.0
Gram-positive bacteria
         
Compound                       pH
B. subtilis           
ATCC 6051
B. cereus         
Difco Spores
B. polymyxa   
ATCC 842
LM1            
ATCC 7644
LM2                
UK ADL
LM3              
ATCC 49594
C1                     
RNR
NA < 20.0 < 15.0 NA < 5.0
C2         
ATCC 8260
< 5.0
Coumarin < 20.0 NA NA NA < 10.0 NA NA NA < 20.0
Chlorogenic a.
C3           
ATCC 7955
Capsaicin NA < 20.0 < 10.0 < 5.0
NA
Ellagic a. < 20.0 < 20.0 NA < 5.0 < 5.0 < 5.0 < 5.0 < 15.0 NA
Decanol NA NA NA < 20.0 < 20.0 < 20.0 < 15.0 < 20.0
< 5.0
Myricetin < 15.0 < 15.0 NA NA NA NA NA NA < 5.0
(-) Epicatechin NA < 10.0 NA NA NA NA NA NA
< 5.0 < 5.0
< 15.0
Rutin NA < 20.0 < 20.0 NA NA NA < 20.0 NA NA
Quercetin < 10.0 < 10.0 < 10.0 NA NA NA NA NA
< 10.0Tannic a. < 20.0 NA NA < 5.0 < 10.0 < 15.0
NA < 20.0 NA
5.4
5.62
6.1
4.77
5.44
5.6
6.46
7.18
5.65
5.4
NA
Tannic a. < 20.0 NA < 10.0 < 15.0 < 20.0 < 10.0
Rutin < 20.0 NA < 15.0 NA NA
< 10.0
Quercetin NA NA < 5.0 < 20.0 < 15.0 NA
Myricetin < 15.0 < 10.0 < 10.0 < 15.0 NA
< 15.0
(-) Epicatechin < 20.0 NA < 15.0 < 10.0 NA NA
Ellagic a. < 10.0 < 5.0 NA NA < 15.0
< 20.0
Decanol < 20.0 < 20.0 < 20.0 < 15.0 < 5.0 < 10.0
Coumarin < 20.0 NA NA < 20.0 < 15.0
< 15.0
Chlorogenic a. < 10.0 NA < 15.0 < 5.0 < 15.0 NA
Capsaicin NA NA NA < 10.0 < 20.0
Gram-negative bacteria
  Compound                       pH E. coli                                   FTJ
E. coli 0157:H7             
ATCC 43895
E. coli 0157:H7                    
ATCC 35150
S. paratyphi              
UK Micro 29A
S. cholerasuis subsp. 
ATCC 10708
S. enteridis                             
(-) H2S
102 
103 
 
 
Figure 5.1. The antimicrobial activity of capsaicin at MIC of 15 ppm against B. subtilis, 
ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.2. The antimicrobial activity of capsaicin at MIC of 20 ppm against B. 
polymyxa, ATCC 842. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.3. The antimicrobial activity of capsaicin at MIC of 10 ppm against L. 
monocytogenes, ATCC 49594. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 5.4. The average antimicrobial activity of capsaicin at MIC of 5 ppm against C. 
perfringens, RNR, C. butyricum, ATCC 8260 and C. sporogenes, ATCC 7955. Error bars 
represent standard deviation from the mean, P<0.05. 
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Figure 5.5. The antimicrobial activity of capsaicin at MIC of 20 ppm against E. coli 
O157:H7, ATCC 43895. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.6. The average antimicrobial activity of capsaicin at MIC of 20 ppm against S. 
paratyphi, UK Micro 29A, S. cholerasuis subsps., ATCC 10708 and S. enteridis, (-) H2S. 
Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.7. The antimicrobial activity of chlorogenic acid at MIC of 10 ppm against B. 
cereus, Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.8. The antimicrobial activity of chlorogenic acid at MIC of 20 ppm against C. 
butyricum, ATCC 8260. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.9. The antimicrobial activity of chlorogenic acid at MIC of 5 ppm against C. 
sporogenes, ATCC 7955. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.10. The antimicrobial activity of chlorogenic acid at MIC of 10 ppm against E. 
coli O157:H7, ATCC 35150. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 5.11. The antimicrobial activity of coumarin at MIC of 10 ppm against C. 
butyricum, ATCC 8260. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.12. The antimicrobial activity of coumarin at MIC of 5 ppm against C. 
sporogenes, ATCC 7955. Error bars represent standard deviation from the mean, P<0.05. 
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0.8 
0.9 
0 12 24 36 48 60 
A
bs
or
ba
nc
e 
at
 6
60
 n
m
 
Time (hours) 
Coumarin 
Control 
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0.8 
0.9 
0 12 24 36 48 60 
A
bs
or
ba
nc
e 
at
 6
60
 n
m
 
Time (hours) 
Coumarin 
Control 
109 
 
 
Figure 5.13. The antimicrobial activity of coumarin at MIC of 5 ppm against S. enteridis, 
(-) H2S. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.14. The antimicrobial activity of decanol at MIC of 5 ppm against B. subtilis, 
ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.15. The antimicrobial activity of decanol at MIC of 10 ppm against B. cereus, 
Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.16. The antimicrobial activity of decanol at MIC of 5 ppm against B. polymyxa, 
ATCC 842. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.17. The antimicrobial activity of decanol at MIC of 20 ppm against L. 
monocytogenes, UK ADL. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 5.18. The antimicrobial activity of decanol at MIC of 5 ppm against C. butyricum 
ATCC 8260. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.19. The antimicrobial activity of decanol at MIC of 10 ppm against E. coli, FTJ. 
Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.20. The average antimicrobial activity of decanol at MIC of 5 ppm against E. 
coli O157:H7, ATCC 43895 and E. coli O157:H7, ATCC 35150. Error bars represent 
standard deviation from the mean, P<0.05. 
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Figure 5.21. The antimicrobial activity of decanol at MIC of 10 ppm against S. enteridis, 
(-) H2S. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.22. The antimicrobial activity of ellagic acid at MIC of 10 ppm against B. 
subtilis, ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.23. The antimicrobial activity of ellagic acid at MIC of 10 ppm against B. 
cereus, Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
 
Figure 5.24. The average antimicrobial activity of ellagic acid at MIC of 5 ppm against 
L. monocytogenes, ATCC 7644, L. monocytogenes, UK ADL. and L. monocytogenes, 
ATCC 49594. Error bars represent standard deviation from the mean, P<0.05. Error bars 
represent standard deviation from the mean, P<0.05. 
0 
0.5 
1 
1.5 
2 
2.5 
3 
0 12 24 36 48 60 72 
A
bs
or
ba
nc
e 
at
 6
60
 n
m
 
Time (hours) 
Ellagic acid 
Control 
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
0 12 24 36 48 60 
A
bs
or
ba
nc
e 
at
 6
60
 n
m
 
Time (hours) 
Ellagic acid 
Control 
115 
 
 
Figure 5.25. The antimicrobial activity of ellagic acid at MIC of 20 ppm against E. coli, 
FTJ. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.26. The antimicrobial activity of ellagic acid at MIC of 20 ppm against E. coli 
O157:H7, ATCC 43895. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.27. The antimicrobial activity of ellagic acid at MIC of 10 ppm against S. 
cholerasuis subsps., ATCC 10708. Error bars represent standard deviation from the 
mean, P<0.05. 
 
 
Figure 5.28. The antimicrobial activity of (-) epicatechin at MIC of 20 ppm against B. 
polymyxa, ATCC 842. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.29. The antimicrobial activity of (-) epicatechin at MIC of 20 ppm against C. 
butyricum, ATCC 8260. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.30. The antimicrobial activity of (-) epicatechin at MIC of 10 ppm against C. 
sporogenes, ATCC 7955. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.31. The antimicrobial activity of (-) epicatechin at MIC of 20 ppm against E. 
coli, FTJ. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.32. The average antimicrobial activity of (-) epicatechin at MIC of 15 ppm 
against S. paratyphi, UK Micro 29A, S. cholerasuis subsps., ATCC 10708 and S. 
enteridis, (-) H2S . Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.33. The antimicrobial activity of myricetin at MIC of 15 ppm against B. cereus, 
Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.34. The antimicrobial activity of myricetin at MIC of 5 ppm against C. 
butyricum, ATCC 8260. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.35. The antimicrobial activity of myricetin at MIC of 10 ppm against C. 
sporogenes, ATCC 8955. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.36. The antimicrobial activity of myricetin at MIC of 20 ppm against E. coli, 
FTJ. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.37. The antimicrobial activity of myricetin at MIC of 15 ppm against S. 
cholerasuis subsp., ATCC 10708. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 5.38. The antimicrobial activity of quercetin at MIC of 10 ppm against B. 
polymyxa, ATCC 842. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.39. The antimicrobial activity of quercetin at MIC of 15 ppm against C. 
butyricum, ATCC 8260. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.40. The antimicrobial activity of quercetin at MIC of 15 ppm against C. 
sporogenes, ATCC 7955. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.41. The average antimicrobial activity of quercetin at MIC of 5 ppm against E. 
coli, FTJ, E. coli O157:H7, ATCC 43895, and E. coli O157:H7, ATCC 35150. Error bars 
represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.42. The antimicrobial activity of quercetin at MIC of 15 ppm against S. 
cholerasuis subsp., ATCC 10708. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 5.43. The antimicrobial activity of rutin at MIC of 15 ppm against B. subtilis, 
ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.44. The antimicrobial activity of rutin at MIC of 5 ppm against B. cereus, Difco 
Spores. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.45. The antimicrobial activity of rutin at MIC of 10 ppm against B. polymyxa, 
ATCC 842. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.46. The antimicrobial activity of rutin at MIC of 5 ppm against L. 
monocytogenes, ATCC 7644. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 5.47. The antimicrobial activity of rutin at MIC of 10 ppm against L. 
monocytogenes, UK ADL. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 5.48. The antimicrobial activity of tannic acid at MIC of 20 ppm against C. 
perfringens, RNR. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5.49. The antimicrobial activity of tannic acid at MIC of 20 ppm against C. 
butyricum, ATCC 8260. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.50. The antimicrobial activity of tannic acid at MIC of 20 ppm against E. coli 
O157:H7, ATCC 35150. Error bars represent standard deviation from the mean, P<0.05. 
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CHAPTER 6 
STRUCTURAL CHANGES OF ANTIMICROBIAL TREATED AND NON-
TREATED PATHOGENIC BACTERIA 
6.1 Introduction  
Bacteria are present everywhere: in the soil, deep in the rocks, in all bodies of water, in 
the atmosphere, including the clouds, and also on and inside other living organisms. Their 
effects on higher life forms are known for only a limited number of bacterial species. 
Some are harmful - pathogenic – causing diseases in plants or in animals including 
humans, and some are useful to humans either as “probiotic” bacteria protecting health 
(Hassan and others 2003), or industrially by participating in the production of various 
commodities. The effects of most bacteria are not known. A new trend is in progress 
(Sachs 2008) not to exterminate harmful bacteria in human and animal environments but 
to replace them with beneficial ones. Bacteria which are genetically programmed to die 
after their mission has been accomplished in humans or animals are part of the new trend. 
These minute microorganisms have far reaching macroscopic consequences. They are of 
interest to agriculture because they may harm or improve the production of foods, either 
animal or plant, and thus affect human civilization. 
 
Electron microscopy is one of a limited number of techniques suitable to show bacteria in 
great detail in their natural environment. There are two basic modes, scanning electron 
microscopy (SEM) and transmission electron microscopy (TEM), and each of them uses 
specially designed microscopes. SEM is relatively easy to perform and the results are 
easy to interpret, because the specimens are shown as three-dimensional objects. TEM 
produces different kinds of images based on the fact that the electron beam passes 
through the specimen and forms a shadow-like image on a fluorescent screen which is 
photographed (Kalab and others 2008). The term Scanning Electron Microscope (SEM) 
is used to describe a microscope used to create high magnification, black and white 
images of devices with dimensions from a few tenths of a micron to several millimeters 
in diameter. SEM is also used to describe the photographs taken by the Scanning Electron 
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Microscope. Hence, SEM refers both to the microscope, and the photograph created by 
the microscope. 
Images created with traditional optical microscopes have only a small area that is in 
focus.  They can create quality images of structures that are flat, but can not create good 
images of three dimensional structures because of the focus issues. Scanning Electron 
Microscopes, on the other hand, have a very large depth of field. They can image 
complex three dimensional structures, with all parts of the device being imaged being in 
focus. This large depth of field results in stunning, sharp photographs of very small 
structures. 
SEM also consists of different techniques: 
 
1. Conventional SEM: It is used to visualize bacteria which had been fixed, dehydrated, 
and dried.  
2. Environmental SEM (ESEM): It makes it possible to examine hydrated specimens by 
not exposing them to high vacuum.  
 
A sophisticated technical design keeps the specimen at a temperature several degrees 
above the freezing point of water in a small area inside the microscope where a low 
partial pressure of water vapor provides ions at a concentration sufficient to neutralize 
electrons and thus to prevent charging artifacts (Kaláb and others 1995). 
A scanning electron microscope operates by using a beam of electrons to image 
extremely small structures. The electron beam is created by a cathode typically made of 
tungsten. An electric field is used to accelerate the electron beam towards the cathode, 
where the structure to be imaged is located. Coils or deflector plates are used to scan the 
beam across the sample to be imaged. The resolution that can be achieved depends on the 
spot size of the electron beam. The smaller the beam, the better the resolution can be 
achieved. In order to achieve proper creation, control, and detection of the electron beam, 
the imaging must be done in a vacuum (Bacteria world 2011). In addition, in order to get 
good contrast and resolution, the surface of the device to be imaged must be very 
conductive.  
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In principle, the preparation for SEM consists of isolating the bacteria or trimming the 
specimen where they are present, fixing them, dehydrating in ethanol, critical-point 
drying, mounting on an SEM stub, sputter-coating with conductive material (gold, carbon 
and etc.), and recording images at an appropriate accelerating voltage. Dehydration and 
critical-point drying may disturb bacterial flagella. Sputter coating the fixed and dried 
bacteria with a 20 nm thick layer of conductive material obscures fine structures such as 
pili and fimbriae. However, such structures may be visualized by TEM using negative 
staining or shadowing with platinum (Kalab and others 2008). Glutaraldehyde is a 
commonly used preservative for biological tissues, and it is used in preparation for a wide 
variety of imaging procedures. Glutaraldehyde is an alkylating agent, killing organisms 
and producing a much tougher cell that will resist lysis for extended time periods. It can 
also be used as a buffer solution to maintain pH and osmotic conditions (Lohnes and 
Demirel 1978). For conventional SEM imaging of a non-conductive surface, a metallic 
coating is required to prevent uncontrolled charging and sample damage (Goldstein and 
others 1992). After being treated with phenolic compounds, pathogenic bacteria were 
observed to have morphological changes including deformity in cell walls, cytoplasmic 
membrane and loss of integrity in cells (Filipowicz and others 2003; Packiyasothy and 
Kyle 2002; de Billerbeck and others 2001). 
 
The purpose of this study was to confirm the antimicrobial activity of natural phenolic 
compounds against pathogenic bacteria including both Gram-positives (B. subtilis, B. 
cereus, B. polymyxa, L. monocytogenes spp., C. perfringens, C. sporogenes, and C. 
butyricum) and Gram-negatives (non-pathogenic E. coli, E. coli O157:H7, S. paratyphi, 
S. cholerasuis subsp., and S. enteridis). Scanning electron microscopy (SEM) was 
conducted to get the images of morphological damages in selected pathogenic bacteria. 
 
6.2 Results and Discussion 
Treated samples of pathogenic bacteria using relevant MICs for each, were incubated for 
24 hours at appropriate incubation temperature and conditions. They were then, observed 
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by SEM to investigate the morphological changes in the appearance of the cells. SEM 
observations confirmed the physical damage and considerable morphological alteration to 
all tested Gram-positive and Gram-negative pathogenic bacteria treated with the natural 
phenolic compounds. 
These images directly illustrate the destructive effects of the phenolics on the tested 
bacteria. Non-treated cells (control) were intact and showed a smooth surface (Figure 6.1; 
A1, B1 and Figure 6.2; C1, D1) while bacterial cells treated with the phenolics underwent 
considerable damage (Figure 6.1; A2-A6, B2-B6 and Figure 6.2; C2-C6, D2-D6). 
Although the samples were not prepared quantitatively, it was clearly observed that the 
number of the damaged cells was significantly greater in the treatments than in the 
control. 
There are many possible explanations for the observations. The literature suggests that 
the active components of the plant extracts might bind to the cell surface and then 
penetrate to the target sites, possibly the phospholipid bilayer of the cytoplasmic 
membrane and membrane-bound enzymes (Shan and others 2007a). The effects might 
include the inhibition of proton motive force, inhibition of the respiratory chain and 
electron transfer, and inhibition of substrate oxidation. Uncoupling of oxidative 
phosphorylation, inhibition of active transport, loss of pool metabolites, and disruption of 
synthesis of DNA, RNA, protein, lipid, and polysaccharides might follow (Farag and 
others 1989; Kim and others 1995a). 
The SEM images show that some cells present damage as pores or deformity in the cell 
walls (Figure 6.1; A6, B2, B4 and Figure 6.2; C4 and D3). Some authors have suggested 
that the damage to the cell wall and cytoplasmic membrane was the loss of structural 
integrity and the ability of the membrane to act as a permeability barrier (de Billerbeck 
and others 2001; Packiyasothy and Kyle 2002; Filipowicz and others 2003). Most of the 
cells were observed to get clustered and stick to each other (Figure 6.1; A2, A3, A4, A5, 
A6, B2, B4, B5, and Figure 6.2; C2, C3, C4, C5, C6 and D2, D3, D5, D6). The distortion 
of the cell physical structure would cause the expansion and destabilization of the 
membrane and would increase membrane fluidity, which in turn would increase passive 
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permeability (Ultee and others 2002) and manifest itself as a leakage of various vital 
intracellular constituents, such as ions, ATP, nucleic acids, and amino acids (Kim and 
others 1995b; Cox and others 1998; Helander and others 1998). Most of the Gram- 
negative cells (Figure 6.2; C2, C3, C4, C5, C6, D2, D5, D6) and some of the Gram-
positive cells (Figure 6.1; A2, A5, A6, B2, B3, B4) appeared to be shrunk and even some 
were empty, and the remains were flaccid.  Furthermore, most of the Gram-negative cells 
(Figure 6.2; C2, C5, C6, D3, D5, D6) and two of the L. monocytogenes cells (Figure 6.1; 
B4 and B5) appeared to be stuck together and melted. These images confirm the loss of 
shape and integrity which was followed by the cell death. Cell death may have been the 
result of the extensive loss of cell contents, the exit of critical molecules and ions, or the 
initiation of autolytic processes (Denyer 1990).  
 
6.3 Conclusion 
From all the SEM observations, it seemed that the phenolic compounds caused severe 
damage to the bacteria. In addition, the modes of action of bacterial agents depend on the 
type of microorganisms and are mainly related to their cell wall structure and to the outer 
membrane arrangement. This study and many previous studies (Smith and others 1998; 
Ceylan and others 2004; Lopez and others 2005; Shan and others 2005) indicated that the 
most bioactive compounds of plant extracts were more active against Gram-positive 
bacteria than Gram-negative bacteria. This is likely due to the significant differences in 
the outer layers of Gram-negative and Gram-positive bacteria. Gram-negative bacteria 
possess an outer membrane and a unique periplasmic space which is not found in Gram-
positive bacteria (Duffy and Power 2001). The resistance of Gram-negative bacteria 
toward antibacterial substances is related to the hydrophilic surface of their outer 
membrane which is rich in lipopolysaccharide molecules, presenting a barrier to the 
penetration of numerous antibiotic molecules, and is also associated with the enzymes in 
the periplasmic space, which are capable of breaking down the molecules introduced 
from outside (Gao and others 1999; Shan and others 2007). Gram-positive bacteria do not 
have such an outer membrane and cell wall structure.  
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Consequently, antibacterial substances can penetrate the bacterial cells and easily destroy 
the bacterial cell wall and cytoplasmic membrane and result in a leakage of the cytoplasm 
and its coagulation (Shan and others 2007). Eventually, these disruptions may cause the 
loss of cell integrity and death. 
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Treatment Bacillus subtilis ATCC 6051 
Listeria monocytogenes 
UK ADL 
Control 
  
Chlorogenic 
acid 
  
Myricetin 
  
 
 
Figure 6.1. Scanning electron microscope observations of two selected Gram-positive 
pathogenic bacteria (A1-A6, B. subtilis B1-B6, L. monocytogenes) treated with the 
natural phenolic compounds (1, control; 2, chlorogenic acid; 3, myricetin; 4, quercetin; 5, 
thymoquinine; 6, xanthohumol).  
A 1 B 1 
A 2 B 2 
A 3 B 3 
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Figure 6.1. continues 
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Treatment E.coli  O157:H7 ATCC 35150 
Salmonella cholerasuis subsp. 
ATCC 10708 
Control 
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Figure 6.2. Scanning electron microscope observations of two selected Gram-negative 
pathogenic bacteria (C1-C6, E. coli O 157: H7 D1-D6, S. cholerasuis subsp.) treated with 
the natural phenolic compounds (1, control; 2, chlorogenic acid; 3, myricetin; 4, 
quercetin; 5, thymoquinine; 6, xanthohumol). 
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Figure 6.2. continues 
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CHAPTER 7 
OVERALL CONCLUSIONS 
The results of these studies demonstrate that different natural antimicrobials of plant 
origin can effectively reduce or inhibit pathogenic and spoilage microorganisms, thus 
providing a good alternative to the use of traditional antimicrobials. This project also 
shows that chemical structure plays an important role in pathogenic bacteria’s cell growth 
inhibition. 
The natural phenolic compounds extracted from vegetables, fruits, herbs and spices have 
high potential to reduce and/or inhibit the growth of most common pathogenic bacteria. 
Generally, Gram-negative bacteria (E. coli and Salmonella) and Gram-positives (Bacilli, 
Listeria monocytogenes, and Clostridium) were observed to have different degrees of 
antimicrobial susceptibility. These variations may stem from the differences in cell 
surface structures between Gram-negative and Gram-positive bacteria. In particular, the 
outer membrane of Gram-negative bacteria functions as a preventive barrier against 
hydrophobic compounds.  
Furthermore, different strains of the same family showed varying degrees of 
antimicrobial susceptibility, with different concentrations of phenolic compounds. 
Therefore, each phenolic compound had different MIC for each bacterial strain. The 
results of this study suggest that the sensitivity of the pathogenic bacteria to phenolic 
compounds depends on bacterial species and polyphenol structure of the phenolics. The 
usage of plant based antimicrobials can be alternatives for chemicals used in food 
preservation. In fact, phenolic compounds in plant extracts have potential inhibitory 
activity against pathogenic bacteria. Moreover, the genetic diversity, agronomical 
practices, environmental conditions, and the composition of critical compounds in herb 
and plant extracts exhibit differences in their efficacy against foodborne pathogens. 
It should be kept in mind that the addition of antimicrobials to the food products without 
adversely affecting the sensory characteristics is still a challenge for researchers, since 
the concentrations that are necessary to ensure safety of food and food products are 
several times higher than those accepted by consumers from sensory point of view. 
Therefore, new studies combining the use of antimicrobials with other methodologies of 
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food preservation are necessary to reduce the impact of these compounds on sensory 
properties. Further research is also needed to better understand the impact of natural 
phenolic compounds on pathogens, their organoleptic properties on food and their 
relevant use in food applications. 
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APPENDICES 
 
Figure 1. The antimicrobial activity of curcumin at MIC of 15 ppm against B. subtilis, 
ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
 
Figure 2. The antimicrobial activity of curcumin at MIC of 5 ppm against E. coli 
O157:H7, ATCC 35150. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 3. The antimicrobial activity of curcumin at MIC of 5 ppm against S. paratyphi, 
UK Micro 29A. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 4. The antimicrobial activity of curcumin at MIC of 20 ppm against S. enteridis, 
(-) H2S. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 5. The antimicrobial activity of Eugenol at MIC of 20 ppm against B. polymyxa, 
ATCC 842. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 6. The antimicrobial activity of eugenol at MIC of 5 ppm against L. 
monocytogenes, ATCC 7644. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 7. The antimicrobial activity of eugenol at MIC of 10 ppm against L. 
monocytogenes, UK ADL. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 8. The antimicrobial activity of eugenol at MIC of 5 ppm against L. 
monocytogenes, ATCC 49594. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 9. The antimicrobial activity of eugenol at MIC of 10 ppm against S. paratyphi, 
UK Micro 29A. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 10. The antimicrobial activity of gallic acid at MIC of 5 ppm against L. 
monocytogenes, UK ADL. Error bars represent standard deviation from the mean, 
P<0.05.    
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Figure 11. The antimicrobial activity of gallic acid at MIC of 10 ppm against L. 
monocytogenes, ATCC 49594. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 12. The antimicrobial activity of gallic acid at MIC of 15 ppm against S. 
paratyphi, UK Micro 29A. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 13. The antimicrobial activity of rosmarinic acid at MIC of 15 ppm against B. 
subtilis, ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 14. The antimicrobial activity of rosmarinic acid at MIC of 15 ppm against B. 
polymyxa, ATCC 842. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 15. The antimicrobial activity of rosmarinic acid at MIC of 15 ppm against S. 
enteridis,  (-) H2S. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 16. The antimicrobial activity of thymol at MIC of 20 ppm against B. subtilis, 
ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 17. The antimicrobial activity of thymol at MIC of 15 ppm against S. paratyphi, 
UK Micro 29A. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 18. The antimicrobial activity of thymol at MIC of 15 ppm against S. cholerasuis 
subsp., ATCC 10708. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 19. The antimicrobial activity of thymoquinine at MIC of 5 ppm against B. 
subtilis, ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 20. The antimicrobial activity of thymoquinine at MIC of 10 ppm against B. 
polymyxa, ATCC 842. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 21. The average antimicrobial activity of thymoquinine at MIC of 10 ppm against 
L. monocytogenes, ATCC 7644, L. monocytogenes, UK ADL and L. monocytogenes, 
ATCC 49594. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 22. The antimicrobial activity of thymoquinine at MIC of 20 ppm against S. 
paratyphi, UK Micro 29A. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 23. The antimicrobial activity of xanthohumol at MIC of 5 ppm against B. 
polymyxa, ATCC 840. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 24. The antimicrobial activity of xanthohumol at MIC of 15 ppm against E. coli 
O157:H7, ATCC 43895. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 25. The antimicrobial activity of xanthohumol at MIC of 20 ppm against S. 
paratyphi, UK Micro 29A. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 26. The antimicrobial activity of xanthohumol at MIC of 15 ppm against S. 
cholerasuis subsps., ATCC 10708. Error bars represent standard deviation from the 
mean, P<0.05 
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Figure 27. The antimicrobial activity of capsaicin at MIC of 20 ppm against B. cereus, 
Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 28. The antimicrobial activity of capsaicin at MIC of 20 ppm against L. 
monocytogenes, UK ADL. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 29. The antimicrobial activity of capsaicin at MIC of 20 ppm against E. coli, FTJ. 
Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 30. The antimicrobial activity of chlorogenic acid at MIC of 10 ppm against B. 
polymyxa, ATCC 842. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 31. The average antimicrobial activity of chlorogenic acid at MIC of 10 ppm 
against L. monocytogenes, ATCC 7644, L. monocytogenes, UK ADL and L. 
monocytogenes, ATCC 49594. Error bars represent standard deviation from the mean, 
P<0.05. Error bars represent standard deviation from the mean, P<0.05. 
 
Figure 32. The antimicrobial activity of chlorogenic acid at MIC of 15 ppm against E. 
coli, FTJ. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 33. The average antimicrobial activity of chlorogenic acid at MIC of 10 ppm 
against S. paratyphi, UK Micro 29A, S. cholerasuis subsp. ATCC 10708 and S. enteridis, 
(-) H2S. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 34. The antimicrobial activity of coumarin at MIC of 20 ppm against B. subtilis, 
ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 35. The antimicrobial activity of coumarin at MIC of 5 ppm against B. cereus, 
Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 36. The antimicrobial activity of coumarin at MIC of 15 ppm against B. 
polymyxa, ATCC 842. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 37. The antimicrobial activity of coumarin at MIC of 5 ppm against L. 
monocytogenes, ATCC 7644. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 38. The antimicrobial activity of coumarin at MIC of 5 ppm against L. 
monocytogenes, UK ADL. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 39. The antimicrobial activity of coumarin at MIC of 15 ppm against L. 
monocytogenes, ATCC 49594. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 40. The antimicrobial activity of coumarin at MIC of 20 ppm against E.coli, FTJ. 
Error bars represent standard deviation from the mean, P<0.05. 
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Figure 41. The antimicrobial activity of coumarin at MIC of 15 ppm against S. 
paratyphi, UK Micro 29A. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 42. The antimicrobial activity of coumarin at MIC of 15 ppm against S. 
cholerasuis subsp., ATCC 10708. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 43. The antimicrobial activity of decanol at MIC of 20 ppm against L. 
monocytogenes, ATCC 49594. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 44. The antimicrobial activity of decanol at MIC of 5 ppm against C. perfringens, 
RNR. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 45. The antimicrobial activity of decanol at MIC of 15 ppm against S. paratyphi, 
UK Micro Lab. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 46. The antimicrobial activity of decanol at MIC of 15ppm against S. cholerasuis 
subsp., ATCC 10708. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 47. The antimicrobial activity of ellagic acid at MIC of 5 ppm against B. 
polymyxa, ATCC 842. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 48. The antimicrobial activity of ellagic acid at MIC of 5 ppm against C. 
perfringens, RNR. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 49. The antimicrobial activity of ellagic acid at MIC of 15 ppm against C. 
butyricum, ATCC 8260. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 50. The antimicrobial activity of ellagic acid at MIC of 20 ppm against S. 
paratyphi, UK Micro 29A. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 51. The antimicrobial activity of ellagic acid at MIC of 15 ppm against S. 
enteridis,        (-) H2S. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 52. The antimicrobial activity of (-) epicatechin at MIC of 20 ppm against B. 
subtilis, ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 53. The antimicrobial activity of (-) epicatechin at MIC of 20 ppm against B. 
cereus, Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 54. The antimicrobial activity of (-) epicatechin at MIC of 5 ppm against L. 
monocytogenes, UK ADL. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 55. The antimicrobial activity of (-) epicatechin at MIC of 5 ppm against L. 
monocytogenes, ATCC 49594. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 56. The antimicrobial activity of (-) epicatechin at MIC of 20 ppm against C. 
perfringens, RNR. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 57. The antimicrobial activity of (-) epicatechin at MIC of 5 ppm against E. coli 
O157:H7, ATCC 43895. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 58. The antimicrobial activity of (-) epicatechin at MIC of 10 ppm against E. coli 
O157:H7, ATCC 35150. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 59. The antimicrobial activity of myricetin at MIC of 15 ppm against B. subtilis, 
ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 60. The antimicrobial activity of myricetin at MIC of 10 ppm against E. coli 
O157:H7, ATCC 43895. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 61. The antimicrobial activity of myricetin at MIC of 15 ppm against E. coli 
O157:H7, ATCC 35150. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 62. The antimicrobial activity of myricetin at MIC of 20 ppm against S. 
paratyphi, UK Micro 29A. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 63. The antimicrobial activity of Myricetin at MIC of 5 ppm against S. enteridis, 
(-) H2S. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 64. The antimicrobial activity of quercetin at MIC of 15 ppm against B. subtilis, 
ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 65. The antimicrobial activity of quercetin at MIC of 20 ppm against B. cereus, 
Difco Spores. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 66. The antimicrobial activity of quercetin at MIC of 20 ppm against S. paratyphi, 
UK Micro 29A. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 67. The antimicrobial activity of quercetin at MIC of 10 ppm against S. enteridis, 
(-) H2S. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 68. The antimicrobial activity of rutin at MIC of 15 ppm against L. 
monocytogenes, ATCC 49594. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 69. The antimicrobial activity of rutin at MIC of 10 ppm against C. perfringens, 
RNR. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 70. The antimicrobial activity of rutin at MIC of 20 ppm against E. coli, FTJ. 
Error bars represent standard deviation from the mean, P<0.05. 
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Figure 71. The antimicrobial activity of rutin at MIC of 5 ppm against E. coli O157:H7, 
ATCC 43895. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 5.72. The antimicrobial activity of rutin at MIC of 15 ppm against E. coli 
O157:H7, ATCC 35150. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 73. The antimicrobial activity of rutin at MIC of 20 ppm against S. paratyphi, UK 
Micro 29A. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 74. The antimicrobial activity of rutin at MIC of 15 ppm against S. cholerasuis 
subsp., ATCC 10708. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 75. The antimicrobial activity of rutin at MIC of 15 ppm against S. enteridis, (-) 
H2S. Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 76. The antimicrobial activity of tannic acid at MIC of 20 ppm against B. subtilis, 
ATCC 6051. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 77. The antimicrobial activity of tannic acid at MIC of 10 ppm against L. 
monocytogenes, ATCC 7644. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 78. The antimicrobial activity of tannic acid at MIC of 15 ppm against L. 
monocytogenes, UK ADL. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 79. The antimicrobial activity of tannic acid at MIC of 20 ppm against L. 
monocytogenes, ATCC 49594. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 80. The antimicrobial activity of tannic acid at MIC of 10 ppm against C. 
sporogenes, ATCC 7955. Error bars represent standard deviation from the mean, P<0.05. 
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Figure 81. The antimicrobial activity of tannic acid at MIC of 5 ppm against E. coli, FTJ. 
Error bars represent standard deviation from the mean, P<0.05. 
 
 
Figure 82. The antimicrobial activity of tannic acid at MIC of 15 ppm against S. 
paratyphi, UK Micro 29A. Error bars represent standard deviation from the mean, 
P<0.05. 
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Figure 83. The antimicrobial activity of tannic acid at MIC of 10 ppm against S. 
cholerasuis subsp., ATCC 10708. Error bars represent standard deviation from the mean, 
P<0.05. 
 
 
Figure 84. The antimicrobial activity of tannic acid at MIC of 15 ppm against S. 
enteridis, (-) H2S. Error bars represent standard deviation from the mean, P<0.05. 
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